Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value
3048522	glukr0	mmol/l (mmol/l)	127	204	0.00%
3048522	glukr-0	MMOL/L (mmol/l)	113	144	0.00%
3048522	gluk0	mmol/l (mmol/l)	100	143	0.00%
3048522	glukras-0	mmol/l (mmol/l)	79	97	0.00%
3048522	glukoosikoe,0näyte	mmol/L (mmol/l)	59	62	0.00%
3048522	0mgluk-r1	mmol/l (mmol/l)	50	51	0.00%
3048522	0mgluk-r1	MMOL/L (mmol/l)	34	42	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diabetes mellitus in pregnancy

151

3.80

25.84

1.7

1.3

5.55

5.40

mmol/l

0.77

151

Gestational diabetes (for exclusion)

104

229

3.13

23.20

1.7

1.4

5.61

5.30

mmol/l

3.01

104

229

Other maternal disorders predominantly related to pregnancy

207

3.00

20.03

1.5

1.2

5.56

5.62

mmol/l

0.26

207

Maternal care for other conditions predominantly related to pregnancy

134

3.94

18.83

1.6

1.2

5.19

5.40

mmol/l

1.01

134

Single delivery by caesarean section

6.62

18.10

1.4

1.2

5.38

6.20

mmol/l

3.21

Abnormal findings on antenatal screening of mother

5.19

15.78

1.7

1.2

5.23

5.15

mmol/l

0.22

Maternal care for other known or suspected fetal problems

110

3.37

14.49

1.7

1.4

5.33

5.59

mmol/l

1.00

110

Delivery

3.87

12.25

1.3

1.1

5.65

6.14

mmol/l

2.36

Delivery, wide proxy

4.14

11.83

1.3

1.1

5.61

6.12

mmol/l

2.48

Maternal care for known or suspected abnormality of pelvic organs

119

3.07

11.82

1.4

5.25

5.65

mmol/l

2.11

119

Other nutritional deficiencies

411

2.16

11.27

1.4

1.3

5.86

5.71

mmol/l

0.77

411

Single spontaneous delivery

3.70

11.09

1.3

1.1

5.70

6.14

mmol/l

1.98

Other obstetric conditions, not elsewhere classified

210

2.38

10.60

1.5

5.16

5.45

mmol/l

2.35

210

Supervision of high-risk pregnancy

3.56

10.29

1.4

5.37

5.95

mmol/l

2.60

Single delivery by forceps and vacuum extractor

5.32

9.99

1.7

1.2

5.15

6.15

mmol/l

4.00

Premature rupture of membranes

104

3.02

9.59

1.5

1.4

5.08

5.61

mmol/l

5.10

104

Pregnancy, childbirth and the puerperium

4.16

9.43

1.4

1.1

5.70

6.11

mmol/l

1.48

Obesity related asthma

161

2.80

9.39

1.3

1.2

6.14

5.92

mmol/l

0.78

161

Obesity

407

2.06

9.33

1.4

1.3

5.91

5.70

mmol/l

1.07

407

Obesity and other hyperalimentation

411

2.04

9.06

1.4

1.3

5.91

5.71

mmol/l

1.03

411

Obesity due to excess calories

324

2.19

8.86

1.4

1.3

5.88

5.70

mmol/l

0.73

324

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

205

2.25

8.72

1.5

5.16

5.42

mmol/l

2.01

205

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

11.73

8.59

1.7

1.2

5.05

5.58

mmol/l

1.19

Non-invasive ventilation

120

2.88

8.52

1.4

1.2

5.95

5.51

mmol/l

0.83

120

Polyhydramnios

4.77

8.11

1.6

1.2

5.29

5.63

mmol/l

0.96

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

304

2.06

7.48

1.5

1.4

5.62

5.56

mmol/l

0.21

304

Spondylosis

163

2.40

7.35

1.1

6.23

6.22

mmol/l

0.03

163

Other and unspecified nerve root and plexus disorders, also in other diseases

103

2.92

6.83

1.2

6.32

6.00

mmol/l

0.40

103

Carpal tunnel syndrome

286

2.00

6.44

1.3

1.2

5.94

5.98

mmol/l

0.12

286

Procreative management

104

2.69

6.43

1.4

1.3

5.50

6.01

mmol/l

2.59

104

False labour

131

2.32

6.40

1.5

1.3

5.28

5.67

mmol/l

1.97

131

Asthma (mode)

277

1.82

6.38

1.3

6.08

5.74

mmol/l

1.42

277

Maternal care for known or suspected malpresentation of fetus

2.65

6.37

1.6

1.4

5.21

5.55

mmol/l

1.78

Pregnancy hypertension

301

1.96

6.15

1.5

1.4

5.62

5.54

mmol/l

0.28

301

Gestational [pregnancy-induced] hypertension

219

2.19

6.10

1.5

1.4

5.41

5.45

mmol/l

0.11

219

Asthma, excluding more controls

264

1.81

6.05

1.3

6.09

5.71

mmol/l

1.66

264

Asthma, hospital admissions , main diagnosis only

450

1.76

6.03

1.3

6.06

5.70

mmol/l

1.46

450

Asthma (only as main-diagnosis), excluding more controls

264

1.82

5.91

1.3

6.09

5.71

mmol/l

1.51

264

Asthma

275

1.78

5.91

1.3

6.09

5.74

mmol/l

1.53

275

Asthma, including avohilmo

126

428

1.62

5.69

1.3

5.95

5.75

mmol/l

0.90

126

428

Presence of other devices

2.85

5.69

1.2

5.99

6.13

mmol/l

0.43

Retained placenta and membranes, without haemorrhage

3.06

5.48

1.3

1.2

5.25

5.84

mmol/l

3.00

Postpartum care and examination

3.21

5.45

1.4

1.6

5.31

5.75

mmol/l

1.10

Asthma (only as main-diagnosis)

275

1.77

5.42

1.3

6.09

5.74

mmol/l

1.35

275

Spinal stenosis

119

2.35

5.40

1.2

1.1

6.18

6.27

mmol/l

0.27

119

Asthma (diagnoses ohter than nonallergic)

452

1.66

5.04

1.2

1.3

6.08

5.71

mmol/l

1.68

452

Dental pulpitis, including avohilmo

105

419

1.60

4.78

1.4

1.3

5.76

mmol/l

0.01

105

419

Persons encountering health services in circumstances related to reproduction

163

2.02

4.74

1.2

5.87

6.19

mmol/l

1.37

163

Spondylopathies

233

1.78

4.55

1.2

6.20

5.94

mmol/l

1.59

233

Other intervertebral disc disorders

298

1.68

4.52

1.2

1.3

6.22

5.78

mmol/l

2.06

298

Examination and observation for other reasons

218

1.79

4.52

1.3

5.67

5.83

mmol/l

0.67

218

Contact with and exposure to communicable diseases

281

0.28

4.47

1.4

1.5

5.55

5.40

mmol/l

—

281

Obstructed labour due to malposition and malpresentation of fetus

168

2.10

4.37

1.5

1.4

5.23

5.61

mmol/l

1.60

168

Maternal care related to the fetus and amniotic cavity and possible delivery problems

162

1.92

4.37

1.4

1.3

5.38

5.81

mmol/l

2.99

162

Nerve, nerve root and plexus disorders

106

408

1.56

4.29

1.3

6.01

5.81

mmol/l

0.80

106

408

Prolonged pregnancy

2.38

4.12

1.8

1.4

4.90

5.55

mmol/l

6.34

Dental caries, including avohilmo

154

1.86

4.11

1.1

1.2

6.03

5.88

mmol/l

0.72

154

Sulfonylureas

0.00

4.09

0.0

1.2

—

6.15

—

Pregnancy examination and test

2.73

4.05

1.5

5.35

5.87

mmol/l

1.80

Dental operations

109

2.03

4.02

1.2

6.05

6.07

mmol/l

0.05

109

Caries of dentine, including avohilmo

178

1.78

3.98

1.1

1.3

6.06

5.81

mmol/l

1.38

178

Lumbar disc prolapse

272

1.72

3.87

1.2

6.31

5.84

mmol/l

1.61

272

Rheumatism, unspecified

3.69

3.78

1.3

1.2

5.78

5.94

mmol/l

0.34

Asthma, unspecified (mode), excluding more controls

238

1.74

3.76

1.2

1.3

6.26

5.75

mmol/l

3.16

238

Type 2 diabetes, definitions combined, including avohilmo

336

1.57

3.76

1.3

6.73

5.63

mmol/l

10.49

336

Bleeding

326

0.43

3.66

1.3

1.2

6.15

6.12

mmol/l

0.06

326

Complications of labour and delivery

235

1.66

3.59

1.4

5.47

5.68

mmol/l

1.13

235

Perineal laceration during delivery

135

2.04

3.59

1.6

1.5

5.01

5.35

mmol/l

3.55

135

Diabetic nephropathy, excluding more controls

0.00

3.54

0.0

1.2

—

6.69

—

Chronic lower respiratory diseases

120

433

1.46

3.54

1.3

5.98

5.74

mmol/l

1.09

120

433

261

1.79

3.52

1.3

5.98

5.63

mmol/l

0.71

261

Persons with potential health hazards related to communicable diseases

321

0.34

3.50

1.3

1.4

5.55

5.46

mmol/l

0.15

321

Labour and delivery complicated by fetal stress [distress]

149

1.88

3.49

1.7

1.5

5.24

5.41

mmol/l

0.75

149

Asthma-related infections

330

1.68

3.47

1.3

6.09

5.72

mmol/l

0.92

330

Asthma, hospital admission 2, infections

330

1.68

3.47

1.3

6.09

5.72

mmol/l

0.92

330

Asthma, unspecified (mode)

248

1.69

3.40

1.2

1.3

6.26

5.77

mmol/l

2.97

248

Maternal care for known or suspected fetal abnormality and damage

2.21

3.28

1.8

1.4

5.16

5.60

mmol/l

2.67

Supervision of normal pregnancy

2.25

3.25

1.4

5.22

5.95

mmol/l

3.71

Diabetic retinopathy, strict definition

0.00

3.16

0.0

1.3

—

6.66

—

Gonarthrosis,primary

233

1.63

3.16

1.1

1.2

6.25

6.31

mmol/l

0.17

233

Long labour

168

1.87

3.14

1.3

1.5

5.25

5.51

mmol/l

1.04

168

Insulin, fast-acting (human)

0.00

3.11

0.0

1.3

—

5.63

—

Other diseases of hard tissues of teeth

114

1.86

3.11

1.2

1.3

6.03

5.86

mmol/l

0.65

114

Other spirochaetal diseases, including avohilmo

181

0.28

3.09

1.6

1.2

5.24

5.96

mmol/l

—

181

Unknown and unspecified causes of morbidity

4.01

3.08

1.0

1.4

5.96

5.81

mmol/l

—

Gastro-oesophageal reflux disease

321

1.60

3.05

1.3

1.2

5.94

5.97

mmol/l

0.06

321

Cholelithiasis, broad definition with cholecystitis

335

1.53

3.03

1.2

1.3

6.16

5.86

mmol/l

2.09

335

Disease of hard tissues of teeth, NOS

113

1.85

3.01

1.2

1.3

5.92

5.85

mmol/l

0.17

113

Type 2 diabetes, definitions combined

334

1.50

3.00

1.3

1.2

6.73

5.67

mmol/l

9.30

334

Cholelithiasis

323

1.54

3.00

1.2

1.3

6.15

5.87

mmol/l

1.81

323

Spirochaetal infections, other/unspecified, including avohilmo

177

0.28

2.95

1.6

1.2

5.24

5.98

mmol/l

—

177

Other spirochaetal diseases

177

0.28

2.95

1.6

1.2

5.24

5.96

mmol/l

—

177

Type 2 diabetes, strict (exclude DM1)

336

1.49

2.93

1.3

1.2

6.73

5.67

mmol/l

9.22

336

Malignant neoplasm of breast, HER2-negative, including Hilmo

156

0.37

2.89

1.2

5.63

6.04

mmol/l

—

156

Malignant neoplasm of breast, including Hilmo

156

0.37

2.89

1.2

5.63

6.04

mmol/l

—

156

Endocrine, nutritional and metabolic diseases

271

1.51

2.86

1.3

1.4

5.88

5.46

mmol/l

3.13

271

Cerebral palsy and other paralytic syndromes

3.16

2.84

1.2

5.75

5.96

mmol/l

0.34

Lyme disease

174

0.29

2.80

1.6

1.2

5.24

5.96

mmol/l

—

174

Lyme disease, including avohilmo

174

0.29

2.80

1.6

1.2

5.24

5.96

mmol/l

—

174

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

2.65

2.79

1.3

1.2

6.10

5.68

mmol/l

1.20

Malignant neoplasm of breast

153

0.38

2.76

1.2

5.63

6.04

mmol/l

—

153

Cholecystectomy

319

1.57

2.75

1.2

6.13

5.90

mmol/l

1.10

319

Spontaneous abortion

244

1.59

2.75

1.6

1.3

5.46

5.53

mmol/l

0.24

244

Haemorrhage in early pregnancy

154

1.89

2.75

1.3

1.2

5.53

5.55

mmol/l

0.03

154

Other gastritis (incl. Duodenitis)

2.31

2.74

1.3

1.2

5.97

6.13

mmol/l

0.25

Postpartum haemorrhage

172

1.78

2.71

1.4

1.5

5.16

5.54

mmol/l

2.56

172

Insulin, combination of fast acting with intermediate-acting or long-acting

296

0.43

2.71

1.4

1.2

7.48

5.96

mmol/l

1.22

296

Additional codes for the location of defect, injury or illness

3.76

2.67

1.6

1.3

6.17

5.86

mmol/l

—

Malignant neoplasm of breast, HER2-negative

152

0.38

2.62

1.2

5.63

6.05

mmol/l

—

152

Diabetic nephropathy

0.00

2.60

0.0

1.2

—

6.67

—

Diseases of pulp and periapical tissues and dental caries

132

1.71

2.59

1.2

1.3

6.02

5.88

mmol/l

0.48

132

Diseases of oral cavity, salivary glands and jaws

114

1.76

2.55

1.2

1.3

6.01

5.86

mmol/l

0.49

114

Cholecystitis

2.73

2.54

1.1

1.2

6.59

6.12

mmol/l

0.83

Antepartum haemorrhage, not elsewhere classified

2.42

2.53

1.7

1.2

5.26

5.61

mmol/l

1.09

Insulin, intermediate and long-acting

264

0.40

2.52

1.3

1.2

7.80

5.99

mmol/l

1.11

264

Polypectomy (DHB20)

4.38

2.47

1.0

1.3

6.46

6.31

mmol/l

—

Solid cancers, including Hilmo

345

0.59

2.47

1.1

1.2

5.96

5.98

mmol/l

0.04

345

Diseases of oesophagus, stomach and duodenum

404

1.40

2.47

1.3

6.03

5.81

mmol/l

1.32

404

Special screening examination for infectious and parasitic diseases

152

0.38

2.47

1.3

1.4

5.60

5.56

mmol/l

—

152

Malignant neoplasm, wide definition

351

0.60

2.45

1.1

1.2

5.89

5.98

mmol/l

0.24

351

Malignant neoplasm, including Hilmo

351

0.60

2.44

1.1

1.2

5.89

5.98

mmol/l

0.24

351

Gonarthrosis [arthrosis of knee](FG)

206

1.56

2.43

1.1

1.2

6.25

6.23

mmol/l

0.06

206

Inflammatory diseases of prostate (prostatitis)

3.13

2.43

1.3

1.1

6.41

6.70

mmol/l

—

Urticaria

203

1.73

2.43

1.5

1.3

5.47

5.67

mmol/l

0.73

203

Any event in cancer register

423

0.63

2.41

1.3

5.85

5.80

mmol/l

0.12

423

Asthma/COPD (KELA code 203)

433

1.40

2.41

1.2

1.3

6.05

5.74

mmol/l

1.21

433

Pre-eclampsia or poor fetal growth

279

1.61

2.40

1.7

1.4

5.57

5.43

mmol/l

0.41

279

Persons encountering health services in other circumstances

280

1.59

2.32

1.2

1.3

5.99

5.70

mmol/l

1.48

280

Diseases of pulp and periapical tissues, including avohilmo

345

1.39

2.28

1.2

1.4

5.89

5.67

mmol/l

1.45

345

Non-allergic asthma (mode), excluding more controls

2.07

2.27

1.5

1.2

5.87

5.82

mmol/l

0.06

Diabetic maculopathy

0.00

2.25

0.0

1.3

—

6.55

—

Other and unspecified urticaria

120

1.92

2.24

1.7

1.2

5.39

5.75

mmol/l

1.33

120

Anorexia (incl.atypical)

0.00

2.24

0.0

1.3

—

5.52

—

Mental disorders, not otherwise specified

0.00

2.24

0.0

1.4

—

5.54

—

Diabetic retinopathy

116

0.37

2.24

1.1

1.3

6.71

6.72

mmol/l

—

116

Venous complications and haemorrhoids in pregnancy

5.58

2.21

1.6

1.4

5.44

5.46

mmol/l

—

Contraceptive management

123

1.76

2.20

1.1

1.3

6.02

6.16

mmol/l

0.32

123

Insulin medication

248

0.47

2.20

1.4

1.2

7.48

5.76

mmol/l

1.45

248

Type 2 diabetes

361

1.39

2.20

1.3

6.70

5.62

mmol/l

9.60

361

Episodal and paroxysmal disorders

103

384

1.36

2.19

1.3

1.4

5.81

5.73

mmol/l

0.30

103

384

Antenatal screening

1.95

2.18

1.2

1.4

5.61

5.97

mmol/l

0.99

Impingement syndrome of shoulder

2.13

2.18

1.1

6.42

6.30

mmol/l

0.21

Exposure to unspecified factor

511

0.66

2.17

1.3

5.76

5.80

mmol/l

0.10

511

Non-allergic asthma (mode)

2.03

2.15

1.5

1.2

5.87

5.83

mmol/l

0.05

Sleep apnoea

322

1.43

2.15

1.2

6.27

5.99

mmol/l

1.64

322

Migraine, single triptan purchase ok & required. ICD-code if available is included

365

1.41

2.11

1.3

5.46

5.75

mmol/l

1.91

365

Triptan medication for migraine, single purchase ok

365

1.41

2.11

1.3

5.46

5.75

mmol/l

1.91

365

Acute upper respiratory infections of multiple and unspecified sites

394

1.41

2.11

1.2

1.3

5.95

5.72

mmol/l

1.14

394

Trigger finger

2.45

2.10

1.2

6.56

5.98

mmol/l

1.11

Other arthrosis

161

1.62

2.07

1.2

6.43

6.26

mmol/l

0.59

161

Malignant neoplasm

337

0.63

2.07

1.1

1.2

5.91

6.00

mmol/l

0.25

337

Medicines for HER+ breast cancer

163

0.40

2.03

1.6

1.1

5.31

6.05

mmol/l

—

163

Gonarthrosis

171

1.55

2.03

1.1

1.2

6.22

mmol/l

0.00

171

Implicit viral Sepsis, including avohilmo

163

0.37

1.99

1.5

1.2

5.63

5.97

mmol/l

—

163

Malignant neoplasm

339

0.64

1.95

1.1

1.2

5.91

6.00

mmol/l

0.22

339

Other soft tissue disorders, not elsewhere classified

368

1.36

1.95

1.3

1.4

5.95

5.64

mmol/l

1.89

368

Myocarditis

4.55

1.94

1.6

1.2

5.60

5.69

mmol/l

—

Sleep apnoea, including avohilmo

351

1.38

1.94

1.2

6.20

5.90

mmol/l

2.00

351

Pruritus

2.19

1.94

1.6

1.3

5.51

5.63

mmol/l

0.18

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

2.57

1.94

1.6

1.2

5.61

5.63

mmol/l

—

Benign lipomatous neoplasm

113

1.86

1.91

1.2

6.02

6.10

mmol/l

0.22

113

Heart failure and antihypertensive medication

2.44

1.90

1.1

1.0

6.34

6.08

mmol/l

0.51

Pre-eclampsia or eclampsia

150

1.74

1.90

1.4

1.3

5.87

5.61

mmol/l

0.66

150

Solid cancers

329

0.64

1.88

1.1

1.2

6.00

6.02

mmol/l

0.04

329

Benign lipomatous neoplasm of other sites/unspecified

3.19

1.88

1.0

1.3

6.06

6.11

mmol/l

—

Other postsurgical states

3.19

1.88

1.3

5.63

5.89

mmol/l

—

Presence of other functional implants

165

0.46

1.87

1.1

6.26

6.29

mmol/l

0.03

165

Parasetamol

247

1.41

1.87

1.3

1.4

5.76

5.65

mmol/l

0.42

247

Obesity, other/unspecified

220

1.59

1.87

1.3

5.90

5.65

mmol/l

0.87

220

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

2.86

1.86

1.0

1.2

5.65

6.02

mmol/l

—

Unspecified urinary incontinence

2.86

1.86

1.4

1.1

6.34

6.11

mmol/l

—

Neurological diseases

301

1.37

1.85

1.3

1.4

5.62

5.67

mmol/l

0.21

301

Heart failure, not strict

210

1.50

1.85

1.1

1.2

6.30

mmol/l

0.00

210

Symptoms and signs involving emotional state

3.54

1.84

1.2

1.4

5.47

5.94

mmol/l

—

Disorders of gallbladder, biliary tract and pancreas

387

1.35

1.83

1.2

1.3

6.21

5.86

mmol/l

2.64

387

Other/unspecified dorsalgia

211

1.59

1.82

1.5

1.2

5.96

5.76

mmol/l

0.62

211

Pain (limb, back, neck, head abdominally)

230

1.42

1.80

1.2

1.3

5.85

5.67

mmol/l

0.86

230

Codes for special purposes

349

0.57

1.79

1.3

5.72

5.73

mmol/l

0.04

349

Pain in joint

228

1.45

1.79

1.2

1.3

6.10

5.67

mmol/l

1.10

228

Provisional assignment of new diseases of uncertain etiology

348

0.57

1.77

1.3

5.71

5.73

mmol/l

0.03

348

Other disorders of amniotic fluid and membranes

1.91

1.77

1.1

1.4

5.17

5.57

mmol/l

1.22

Varicose veins

203

1.53

1.76

1.3

1.1

6.10

6.19

mmol/l

0.23

203

Other (not insulin) diabetes medications

352

1.35

1.76

1.3

6.72

5.68

mmol/l

8.03

352

Spondylolisthesis/Spondylolysis

2.09

1.75

1.2

1.1

6.27

6.15

mmol/l

0.24

Residual foreign body in soft tissue

3.34

1.74

1.0

1.3

6.03

6.08

mmol/l

—

Erectile dysfunction

3.34

1.74

1.2

1.0

6.37

6.29

mmol/l

—

Dyspnoea

399

1.36

1.74

1.2

1.3

5.93

5.89

mmol/l

0.14

399

Degenerative macular diseases

2.50

1.73

1.0

1.1

6.28

6.22

mmol/l

—

Coeliac disease

2.22

1.73

1.4

1.3

5.62

5.73

mmol/l

0.17

Pre-eclampsia

147

1.70

1.73

1.4

1.3

5.84

5.60

mmol/l

0.57

147

Suggestive for eosinophilic asthma

2.67

1.72

1.1

1.3

5.81

5.95

mmol/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

241

1.54

1.72

1.2

1.3

5.93

5.84

mmol/l

0.11

241

Urethral stricture

3.85

1.71

1.2

6.68

6.33

mmol/l

—

Dialysis, with operation codes

0.00

1.70

0.0

1.2

—

6.15

—

Malignant neoplasm of skin, including Hilmo

173

0.50

1.70

1.0

1.2

6.15

6.29

mmol/l

0.23

173

Open wound of ankle and foot

0.00

1.70

0.0

1.3

—

5.79

—

Type 1 diabetes, strict definition, subgroup 1

0.00

1.69

0.0

1.3

—

5.37

—

Fibroblastic disorders

2.00

1.69

1.1

1.2

6.48

6.29

mmol/l

0.23

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

179

0.45

1.68

1.5

1.3

5.45

5.46

mmol/l

—

179

Persons encountering health services for specific procedures, not carried out

0.00

1.68

0.0

1.3

—

5.72

—

Type 1 diabetes, strict definition

0.00

1.68

0.0

1.3

—

5.37

—

Childhood asthma (age<16)

115

1.70

1.66

1.6

1.4

5.49

5.19

mmol/l

0.89

115

Childhood asthma (age<16), excluding more controls

115

1.70

1.66

1.6

1.4

5.49

5.19

mmol/l

0.89

115

Eustachian salpingitis and obstruction

2.50

1.66

1.4

5.67

5.85

mmol/l

—

Flat foot [pes planus] (acquired)

2.50

1.66

1.1

1.2

6.56

6.04

mmol/l

—

Pain in limb

364

1.34

1.66

1.2

1.4

6.15

5.63

mmol/l

3.91

364

Use of disulfiram, acamprosate or naltrexone

2.58

1.66

1.1

1.2

6.04

6.13

mmol/l

—

Bacterial infection, other or unspecified

213

0.51

1.62

1.2

6.22

6.05

mmol/l

0.35

213

L02BG Aromatase inhibitors

129

0.38

1.62

1.8

1.1

5.34

6.04

mmol/l

—

129

Disorders of tooth development and eruption

1.90

1.61

1.2

1.4

5.94

5.57

mmol/l

1.21

Iron deficiency

2.51

1.60

1.3

5.38

5.41

mmol/l

—

Other/unspecified synovitis and tenosynovitis

2.33

1.58

1.7

1.3

5.96

5.87

mmol/l

—

Maternal care for known or suspected disproportion

3.01

1.58

1.5

1.2

5.38

5.86

mmol/l

—

Biomechanical lesions, not elsewhere classified

3.01

1.58

1.0

1.3

5.83

5.98

mmol/l

—

Other disorders of nervous system

3.00

1.58

1.2

5.77

6.29

mmol/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

209

0.48

1.57

1.2

1.3

6.85

5.76

mmol/l

—

209

Dorsalgia

365

1.31

1.57

1.4

5.78

5.65

mmol/l

0.64

365

Acute and transient psychotic disorders

2.20

1.56

1.5

1.2

6.64

5.88

mmol/l

2.64

Urticaria and erythema

247

1.50

1.56

1.5

1.3

5.42

5.72

mmol/l

1.39

247

Neurological diseases, wide definition

121

1.54

1.55

1.3

1.5

5.53

5.32

mmol/l

0.69

121

Superficial injury of lower leg

160

1.63

1.55

1.3

1.2

5.81

5.78

mmol/l

0.06

160

Any death

192

0.55

1.54

1.1

6.52

6.33

mmol/l

0.22

192

Diabetes mellitus

390

1.30

1.53

1.3

6.69

5.57

mmol/l

10.02

390

Other abnormal products of conception

209

1.44

1.53

1.8

1.4

5.60

5.44

mmol/l

0.53

209

Diabetic maculopathy, excluding more controls

0.00

1.52

0.0

1.2

—

5.71

—

Lactose intolerance

3.34

1.52

1.2

1.3

5.72

5.91

mmol/l

—

Biguanides

346

1.33

1.51

1.4

1.2

6.77

5.72

mmol/l

7.57

346

Abnormal findings on diagnostic imaging of central nervous system

2.60

1.51

1.0

1.3

7.46

5.88

mmol/l

—

Autoimmune diseases excluding thyroid diseases

428

0.73

1.51

1.3

5.92

5.78

mmol/l

0.28

428

Familial hypercholesterolemia, with ischemic heart disease

2.86

1.50

1.0

1.1

6.13

6.23

mmol/l

—

Fibromyalgia

2.16

1.50

1.4

1.2

6.02

5.66

mmol/l

1.20

Nephropathy related operations

0.00

1.49

0.0

1.2

—

6.16

—

Other diseases of the digestive system

126

0.40

1.49

1.0

1.2

6.76

6.11

mmol/l

—

126

Acute upper respiratory infections

418

1.29

1.48

1.2

1.3

5.97

5.75

mmol/l

1.23

418

GI-bleeding

129

0.39

1.48

1.0

1.1

6.76

6.09

mmol/l

—

129

Disorders of muscles

2.43

1.47

1.3

1.2

5.60

5.91

mmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

415

0.73

1.47

1.4

1.3

5.90

5.77

mmol/l

0.25

415

Abnormalities of breathing

374

1.30

1.47

1.3

1.4

6.05

5.65

mmol/l

1.81

374

Chronic apical periodontitis

432

1.27

1.44

1.2

1.4

5.97

5.71

mmol/l

1.11

432

Alcohol-induced chronic pancreatitis

3.13

1.44

1.0

1.3

7.46

6.39

mmol/l

—

L02BB Anti-androgens

3.13

1.44

1.4

1.1

6.14

6.32

mmol/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

2.73

1.43

1.5

1.3

6.05

6.10

mmol/l

—

Benign neoplasm: Adrenal gland

2.73

1.43

1.2

1.3

6.13

6.09

mmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

141

1.63

1.41

1.2

1.1

6.10

6.38

mmol/l

0.73

141

Diabetes, varying definitions

387

1.29

1.41

1.3

6.70

5.58

mmol/l

9.75

387

Familial hypercholesterolemia

2.18

1.39

1.0

1.2

6.21

6.33

mmol/l

—

Other disorders of the musculoskeletal system and connective tissue

2.08

1.38

1.3

1.1

5.91

6.07

mmol/l

0.43

Other noninflammatory disorders of uterus, except cervix

1.89

1.37

1.0

1.2

6.06

6.07

mmol/l

0.01

Schizophrenia or delusion

174

1.55

1.36

1.4

1.2

6.39

5.77

mmol/l

4.31

174

Schizophrenia, schizotypal and delusional disorders

174

1.55

1.36

1.4

1.2

6.39

5.77

mmol/l

4.31

174

Disorders of continuity of bone

2.15

1.33

1.2

6.01

5.84

mmol/l

—

Abnormalities of forces of labour

1.91

1.33

1.2

1.1

5.27

5.86

mmol/l

1.27

Transient ischemic attack

145

1.54

1.32

1.1

6.24

6.23

mmol/l

0.03

145

Low back pain

362

1.30

1.31

1.3

1.4

5.91

5.65

mmol/l

1.70

362

Malignant neoplasm of skin

159

0.55

1.31

1.0

1.1

6.22

6.28

mmol/l

0.10

159

Certain infectious and parasitic diseases

403

0.76

1.30

1.2

1.3

5.79

5.78

mmol/l

0.05

403

All pneumoniae

483

0.75

1.30

1.3

6.01

5.78

mmol/l

0.76

483

Other noninflammatory disorders of vagina

2.10

1.30

1.3

1.2

5.33

5.64

mmol/l

—

Rotator cuff syndrome

193

1.43

1.30

1.3

1.2

6.11

6.10

mmol/l

0.04

193

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

275

1.39

1.29

1.2

6.37

6.07

mmol/l

0.54

275

Other septicaemia

162

0.52

1.29

1.0

1.2

6.52

6.06

mmol/l

—

162

Ptosis of eyelid

2.36

1.29

1.1

6.34

6.11

mmol/l

—

Monoamine oxidase A inhibitors

2.35

1.29

1.4

1.1

6.64

6.28

mmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

218

1.35

1.29

1.2

1.3

5.76

5.83

mmol/l

0.25

218

Covid-19 confirmed case

205

0.54

1.27

1.2

5.76

5.87

mmol/l

0.21

205

Allergic asthma (mode), excluding more controls

165

1.54

1.27

1.5

1.4

5.80

5.45

mmol/l

0.38

165

Maltreatment syndromes

2.29

1.27

1.1

1.3

5.90

5.51

mmol/l

—

Septicaemia

175

0.52

1.26

1.0

1.2

6.56

6.07

mmol/l

—

175

Benign neoplasm: Stomach

2.40

1.24

1.2

5.85

6.20

mmol/l

—

Asthma mixed form (mode)

2.40

1.24

1.5

1.2

5.87

5.77

mmol/l

—

Bronchitis, not specified as acute or chronic

2.40

1.24

1.2

1.4

5.85

5.94

mmol/l

—

Asthma mixed form (mode), excluding more controls

2.40

1.24

1.5

1.2

5.87

5.77

mmol/l

—

Other inflammation of eyelid, including avohilmo

351

0.65

1.23

1.2

1.4

5.56

5.64

mmol/l

0.18

351

Schizophrenia or delusion, excluding more controls

177

1.51

1.22

1.4

1.3

6.39

5.74

mmol/l

4.13

177

Allergic asthma (mode)

167

1.52

1.22

1.5

1.4

5.80

5.45

mmol/l

0.38

167

Lateral epicondylitis

2.04

1.22

1.0

1.2

6.08

5.97

mmol/l

—

Hirsutism in women

2.64

1.21

1.0

1.3

6.68

5.47

mmol/l

—

Vocal cord dysfunction

1.98

1.21

1.1

6.52

5.44

mmol/l

2.67

Fever of other and unknown origin

303

0.66

1.21

1.2

1.3

6.05

5.82

mmol/l

0.75

303

Influenza and pneumonia

488

0.77

1.20

1.3

5.88

5.76

mmol/l

0.40

488

Disorders of the thyroid gland

433

1.26

1.20

1.3

1.4

5.83

5.72

mmol/l

0.47

433

DVT of lower extremities and pulmonary embolism

155

1.54

1.20

1.1

6.25

6.19

mmol/l

0.15

155

Other medical care

200

0.59

1.18

1.2

6.22

6.04

mmol/l

0.19

200

Seborrhoeic dermatitis

2.11

1.18

1.3

1.2

6.18

6.02

mmol/l

—

Transplanted organ and tissue status

0.00

1.16

0.0

1.1

—

6.15

—

Abnormal findings on diagnostic imaging of lung

172

1.49

1.15

1.2

1.1

6.11

6.20

mmol/l

0.18

172

Hypertrichosis

2.51

1.15

1.0

1.3

6.68

5.50

mmol/l

—

Benign neoplasm: Parotid gland

2.50

1.15

1.2

1.3

5.54

6.13

mmol/l

—

Shoulder lesions

234

1.33

1.13

1.2

6.07

5.96

mmol/l

0.41

234

Dysphagia

113

0.44

1.12

1.2

1.1

6.00

6.05

mmol/l

—

113

Lichen sclerosus et atrophicus

1.96

1.11

1.1

1.2

6.65

5.96

mmol/l

—

Malignant neoplasm of endocrine gland

2.26

1.10

1.1

1.2

6.20

5.85

mmol/l

—

Other and/or unspecified nontoxic goitre

2.26

1.10

1.3

5.67

5.85

mmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

479

0.78

1.09

1.2

1.3

6.01

5.79

mmol/l

0.76

479

Paralytic strabismus

2.38

1.09

1.0

1.3

5.70

6.18

mmol/l

—

Otosclerosis

2.38

1.09

1.0

1.2

5.72

6.09

mmol/l

—

Atrial fibrillation and flutter with reimbursement

1.82

1.09

1.0

1.1

6.80

6.29

mmol/l

1.14

Sequelae of injuries of upper limb

1.95

1.08

1.1

1.2

6.73

5.95

mmol/l

—

Hydronephrosis

1.95

1.08

1.0

1.2

6.01

5.96

mmol/l

—

Disorders of synovium and tendon

285

1.34

1.08

1.3

6.10

5.76

mmol/l

1.50

285

Chronic laryngitis and laryngotracheitis

1.87

1.07

1.5

1.1

6.39

6.09

mmol/l

0.61

Hypertension, essential

238

1.31

1.06

1.2

6.31

5.88

mmol/l

2.40

238

Implicit Sepsis

327

0.72

1.05

1.3

1.2

6.11

6.03

mmol/l

0.16

327

Hypertensive diseases (excluding secondary)

180

1.36

1.04

1.2

6.29

5.77

mmol/l

2.59

180

Benign paroxysmal vertigo

124

0.48

1.04

1.2

1.1

6.48

6.07

mmol/l

—

124

Migraine with aura

203

1.43

1.04

1.4

5.38

5.44

mmol/l

0.13

203

Congenital deformities of feet, including avohilmo

2.28

1.03

1.0

1.3

5.20

5.79

mmol/l

—

Other and unspecified myopathies

2.27

1.03

1.6

1.2

6.48

6.12

mmol/l

—

Infective dermatitis

1.96

1.03

1.4

1.2

6.63

5.94

mmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

455

0.74

1.03

1.3

5.80

5.75

mmol/l

0.11

455

Other diseases of lip and oral mucosa

240

0.62

1.03

1.1

1.2

6.67

5.91

mmol/l

0.53

240

Gonarthrosis, primary, with knee surgery

164

1.42

1.03

1.1

6.24

6.35

mmol/l

0.29

164

Placenta praevia

2.06

1.03

1.3

1.2

5.20

5.75

mmol/l

—

Benign neoplasm: Transverse colon

2.06

1.02

1.0

1.2

6.34

6.16

mmol/l

—

Autoimmune diseases related-to ILD

492

0.76

1.02

1.3

5.83

5.81

mmol/l

0.05

492

Hypermetropia

2.06

1.02

1.9

1.2

6.16

5.75

mmol/l

—

Hypothyroidism, levothyroxine purchases

131

1.41

1.02

1.4

1.5

5.71

5.28

mmol/l

2.60

131

Hypothyroidism and >3 levothyroxin purchases

131

1.41

1.02

1.4

1.5

5.71

5.28

mmol/l

2.60

131

Nasal polyp

1.73

1.02

1.1

6.22

6.11

mmol/l

0.19

Benign neoplasm of other and unspecified endocrine glands

1.92

1.02

1.2

6.18

6.03

mmol/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

324

1.33

1.01

1.2

1.3

5.89

5.87

mmol/l

0.02

324

Radiculopathy

1.89

1.01

1.2

6.21

6.18

mmol/l

—

Hypothyroidism, other/unspecified

415

1.24

1.00

1.2

1.4

5.84

5.70

mmol/l

0.68

415

Malignant neoplasm of endocrine gland, including Hilmo

2.00

1.00

1.1

1.3

6.20

5.95

mmol/l

—

Other disorders of bladder

2.00

1.00

1.3

1.2

6.70

6.09

mmol/l

—

Astigmatism

2.00

1.00

1.3

5.61

5.69

mmol/l

—

Soft tissue disorders related to use, overuse and pressure

107

1.59

0.99

1.1

1.2

6.44

6.06

mmol/l

0.54

107

Haemorrhage from respiratory passages

119

0.52

0.99

1.4

1.2

5.91

6.07

mmol/l

—

119

Postpartum hemorraghe, all women as controls

267

1.35

0.98

1.4

1.5

5.16

5.40

mmol/l

1.36

267

Other obstructive and reflux uropathy

2.18

0.98

1.0

1.4

5.78

5.77

mmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

2.18

0.98

1.0

1.2

6.44

6.13

mmol/l

—

Spontaneous rupture of synovium and tendon

2.18

0.98

1.2

1.1

5.70

6.17

mmol/l

—

Injuries to the neck

159

0.57

0.98

1.3

5.64

5.71

mmol/l

—

159

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

0.00

0.97

0.0

1.2

—

6.09

—

Diseases of the ear and mastoid process

100

416

1.20

0.97

1.3

5.84

5.75

mmol/l

0.36

100

416

Symptoms and signs involving the circulatory and respiratory systems

375

1.22

0.97

1.3

1.4

5.77

5.66

mmol/l

0.51

375

Plantar fascial fibromatosis

1.95

0.97

1.1

1.3

6.26

6.01

mmol/l

—

Diseases of the myoneural junction and muscle

1.95

0.97

1.4

1.2

6.30

6.10

mmol/l

—

Acute sinusitis

354

0.72

0.97

1.3

1.4

6.10

5.65

mmol/l

0.53

354

Other disorders of eyelid

163

1.45

0.96

1.2

6.16

6.23

mmol/l

0.18

163

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

329

1.31

0.96

1.2

5.87

5.92

mmol/l

0.13

329

Other disorders of optic [2nd] nerve and visual pathways

0.00

0.96

0.0

1.3

—

5.79

—

Blepharochalasis

100

1.60

0.96

1.3

1.1

6.19

6.26

mmol/l

0.13

100

Other and unspecified nonorganic psychotic disorders

108

1.58

0.96

1.5

1.2

6.24

5.61

mmol/l

2.97

108

Intestinal infectious diseases

500

0.79

0.95

1.3

5.80

5.78

mmol/l

0.05

500

Acute nasopharyngitis (common cold)

1.79

0.95

1.0

1.2

6.08

5.94

mmol/l

—

Disorders of choroid and retina

297

0.73

0.95

1.1

1.2

6.24

6.13

mmol/l

0.35

297

Event of undetermined intent

0.00

0.95

0.0

1.3

—

5.81

—

Basal cell carcinoma, including Hilmo

135

0.60

0.94

1.0

1.1

6.18

6.31

mmol/l

0.24

135

Sequelae with surgical and medical care as external cause

1.65

0.94

1.2

6.00

5.97

mmol/l

0.04

Basal cell carcinoma

127

0.59

0.93

1.0

1.1

6.15

6.33

mmol/l

0.28

127

Melanocytic naevi

209

0.62

0.93

1.2

1.3

6.07

5.73

mmol/l

0.39

209

Other functional intestinal disorders

223

0.65

0.93

1.1

1.2

6.11

5.85

mmol/l

0.63

223

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

311

1.31

0.92

1.1

1.3

5.83

5.93

mmol/l

0.32

311

Bacterial Sepsis

183

0.63

0.92

1.1

1.2

6.51

6.13

mmol/l

0.53

183

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.89

0.92

1.1

6.59

6.20

mmol/l

—

Malignant neoplasm of thyroid gland

2.15

0.91

1.2

1.3

6.23

5.87

mmol/l

—

Nontoxic single thyroid nodule

2.15

0.91

1.2

1.3

6.10

5.87

mmol/l

—

Recurrent aphthous stomatitis , including avohilmo

1.67

0.91

1.5

1.2

5.55

5.73

mmol/l

0.42

Hypothyreosis and Thyroxine purchase for inclusion criteria

425

1.22

0.91

1.2

1.4

5.82

5.70

mmol/l

0.59

425

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

467

0.80

0.91

1.2

1.3

6.04

5.79

mmol/l

0.93

467

Pregnancy with abortive outcome

262

1.25

0.90

1.4

1.3

5.69

5.53

mmol/l

0.60

262

Diverticular disease of intestine

204

1.31

0.90

1.1

6.48

6.28

mmol/l

0.82

204

Colorectal cancer, including Hilmo

0.49

0.89

1.2

1.1

6.14

6.29

mmol/l

—

Other diseases of pleura

148

0.59

0.89

1.0

1.1

6.07

6.25

mmol/l

—

148

Scleritis and episcleritis

2.07

0.89

1.3

1.2

5.98

5.84

mmol/l

—

Sicca syndrome [Sjögren]

2.07

0.89

1.2

5.92

5.85

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

384

0.77

0.89

1.3

1.2

6.02

5.94

mmol/l

0.20

384

Use of hypnotics and sedatives

397

1.21

0.89

1.2

1.3

6.14

5.85

mmol/l

1.99

397

Persons encountering health services for specific procedures and health care

472

0.81

0.89

1.3

6.20

5.75

mmol/l

1.50

472

Other antidepressants

354

1.21

0.89

1.2

1.3

5.88

5.80

mmol/l

0.36

354

Cough

204

1.37

0.89

1.2

1.3

6.06

5.84

mmol/l

0.81

204

Acute pharyngitis

103

0.48

0.88

1.4

1.3

5.48

5.43

mmol/l

—

103

Other complications of surgical and medical care, not elsewhere classified

1.91

0.88

1.1

1.3

5.84

5.91

mmol/l

—

Benign neoplasm: Ascending colon

1.91

0.88

1.1

6.31

6.21

mmol/l

—

Palmar fascial fibromatosis [Dupuytren]

1.91

0.88

1.1

1.2

6.67

6.35

mmol/l

—

Oedema, not elsewhere classified

148

1.45

0.88

1.2

6.39

5.98

mmol/l

0.37

148

Assault by bodily force

1.86

0.87

1.0

1.3

5.82

5.66

mmol/l

—

Other embolism and thrombosis

1.86

0.87

1.3

1.1

6.08

6.01

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

2.00

0.87

1.0

1.2

6.03

5.86

mmol/l

—

Malignant neoplasm of thyroid gland, including Hilmo

2.00

0.87

1.2

6.23

5.85

mmol/l

—

Neuromuscular dysfunction of bladder

2.00

0.87

1.3

1.1

5.88

6.07

mmol/l

—

Renal failure

154

0.61

0.86

1.1

6.19

6.26

mmol/l

0.10

154

Conjunctivitis (acute, non atopic)

177

1.41

0.86

1.4

1.3

6.42

5.76

mmol/l

0.84

177

Excessive vomiting in pregnancy

1.82

0.85

1.1

1.2

5.56

5.52

mmol/l

—

Chronic pancreatitis

1.82

0.85

1.0

1.2

7.10

6.26

mmol/l

—

Undetermined asthma, excluding more controls

1.72

0.85

1.3

1.2

5.92

5.81

mmol/l

0.22

Glucosamine medication

128

1.43

0.85

1.0

1.1

6.39

6.23

mmol/l

0.34

128

Percutaneous Coronary Intervention

212

1.29

0.85

1.1

6.30

6.33

mmol/l

0.10

212

Migraine with aura and triptan purchases

145

1.45

0.84

1.4

5.38

5.57

mmol/l

0.63

145

Labour and delivery complicated by umbilical cord complications

1.94

0.84

1.3

1.1

5.53

5.72

mmol/l

—

Coronary revascularization (ANGIO or CABG)

212

1.29

0.84

1.1

6.28

6.33

mmol/l

0.14

212

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

176

1.32

0.84

1.5

1.2

6.14

5.75

mmol/l

1.36

176

ILD differential diagnosis

277

1.23

0.84

1.2

1.3

5.82

5.74

mmol/l

0.28

277

Symptoms and signs concerning food and fluid intake

1.78

0.84

1.3

1.2

6.03

5.90

mmol/l

—

COPD, hospital admission 2, with asthma infections

0.54

0.83

1.0

1.2

6.12

6.30

mmol/l

—

Other problems related to primary support group, including family circumstances

1.62

0.83

1.6

1.3

5.26

5.55

mmol/l

0.75

STROKE

177

1.33

0.83

1.1

1.2

6.45

6.18

mmol/l

0.41

177

Anogenital herpesviral [herpes simplex] infection, including avohilmo

111

0.54

0.83

1.0

1.4

5.25

5.50

mmol/l

—

111

401

1.19

0.83

1.2

1.3

5.97

5.73

mmol/l

1.52

401

Other malignant neoplasms of skin (=non-melanoma skin cancer)

130

0.63

0.83

1.0

1.1

6.12

6.33

mmol/l

0.39

130

Dizziness and giddiness

350

1.24

0.82

1.1

1.2

5.93

5.91

mmol/l

0.04

350

Major coronary heart disease event

220

1.28

0.82

1.1

6.27

6.32

mmol/l

0.16

220

115

0.52

0.82

1.2

1.4

6.08

5.35

mmol/l

—

115

Other septicaemia, including avohilmo

167

0.62

0.82

1.0

1.2

6.52

6.06

mmol/l

0.46

167

COPD differential diagnosis

278

1.23

0.82

1.2

1.3

5.82

5.74

mmol/l

0.28

278

Other enthesopathies

146

1.44

0.82

1.1

1.2

5.97

5.90

mmol/l

0.12

146

Ménière disease

1.88

0.81

1.2

1.1

6.13

6.03

mmol/l

—

Malignant neoplasm of digestive organs, including Hilmo

131

0.62

0.81

1.1

6.21

6.35

mmol/l

0.21

131

Pure hypercholesterolaemia

229

1.27

0.81

1.0

1.2

6.51

6.20

mmol/l

0.69

229

Polyp of the female genital tract

115

0.64

0.80

1.1

1.3

6.10

5.60

mmol/l

1.11

115

Other dorsopathies, not elsewhere classified

365

1.19

0.80

1.3

1.4

5.90

5.65

mmol/l

0.86

365

Mood disorders, excluding more controls

387

1.20

0.80

1.2

1.3

6.00

5.79

mmol/l

1.32

387

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

147

1.43

0.79

1.3

1.2

5.97

6.04

mmol/l

0.16

147

Other retinal disorders

224

0.71

0.79

1.0

1.2

6.36

6.05

mmol/l

1.15

224

Sequelae of injuries of head

0.00

0.79

0.0

1.3

—

6.04

—

Other infective otitis externa

0.00

0.79

0.0

1.3

—

5.90

—

0.00

0.79

0.0

1.1

—

6.37

—

Ill-defined and unknown causes of mortality

0.00

0.79

0.0

1.2

—

6.13

—

Other diseases of biliary tract

0.00

0.79

0.0

1.2

—

6.13

—

Presbycusis

0.00

0.79

0.0

1.1

—

6.32

—

Necrosis of pulp, including avohilmo

396

1.25

0.79

1.2

1.3

5.96

5.81

mmol/l

0.25

396

Covid-19 suspected case

149

0.60

0.78

1.4

1.3

5.66

5.68

mmol/l

—

149

Other disorders of veins

208

0.66

0.78

1.3

1.2

6.04

6.02

mmol/l

0.03

208

Pulmonary heart disease

106

1.51

0.78

1.0

1.2

6.39

6.20

mmol/l

0.45

106

Pulmonary embolism

106

1.51

0.78

1.0

1.2

6.39

6.20

mmol/l

0.45

106

COPD, hospital admissions 1, only main diagnosis

105

0.57

0.78

1.0

1.1

6.30

6.29

mmol/l

—

105

Generalized epilepsy

0.00

0.78

0.0

1.3

—

5.86

—

Preterm labour and delivery

156

1.41

0.78

1.1

1.3

5.46

5.79

mmol/l

0.99

156

Undetermined asthma

1.67

0.78

1.3

1.2

5.92

5.80

mmol/l

0.23

Tinnitus

1.53

0.78

1.3

1.2

6.25

5.95

mmol/l

0.88

Paracetamol or NSAID medication

1.68

0.78

1.5

1.7

5.75

5.24

mmol/l

1.28

Disorders of other endocrine glands

264

1.30

0.78

1.4

1.3

6.37

5.70

mmol/l

1.26

264

Pacemaker

113

0.58

0.78

1.0

1.2

6.03

6.27

mmol/l

—

113

Assault

1.62

0.78

1.1

1.3

5.69

5.68

mmol/l

0.01

Embedded teeth, including avohilmo

1.59

0.78

1.2

1.3

5.59

5.47

mmol/l

0.16

Corneal ulcer

0.52

0.78

1.2

6.46

5.70

mmol/l

—

Allergic contact dermatitis

1.59

0.78

1.4

1.2

5.36

5.73

mmol/l

0.76

Polyarthropathies

277

0.76

0.77

1.2

1.3

6.45

5.80

mmol/l

1.21

277

Conductive and sensorineural hearing loss

259

1.26

0.77

1.2

6.11

6.14

mmol/l

0.07

259

Myocardial infarction, without ST-elevation

118

1.45

0.77

1.2

1.1

6.34

mmol/l

0.00

118

0.00

0.77

0.0

1.3

—

5.47

—

Endometriosis of ovary

118

0.56

0.77

1.0

1.3

5.87

5.57

mmol/l

—

118

Helminthiases, including avohilmo

0.00

0.77

0.0

1.4

—

5.51

—

Care involving dialysis

0.00

0.77

0.0

1.2

—

6.31

—

Asthma-related pneumonia

156

1.41

0.77

1.2

6.29

5.90

mmol/l

0.66

156

Asthma-related pneumonia or sepsis

156

1.41

0.77

1.2

6.29

5.90

mmol/l

0.66

156

Asthma, hospital admissions 3, pneumonia

156

1.41

0.77

1.2

6.29

5.90

mmol/l

0.66

156

Fitting and adjustment of other devices

130

1.42

0.77

1.2

1.1

6.03

6.26

mmol/l

0.86

130

Acute suppurative otitis media

196

0.67

0.77

1.5

1.4

5.90

5.38

mmol/l

1.14

196

Coxarthrosis

133

1.36

0.76

1.1

6.38

6.33

mmol/l

0.15

133

Left ventricular outflow tract obstruction (LVOTO), broad definition

1.77

0.76

1.0

1.2

5.87

6.19

mmol/l

—

Coxarthrosis [arthrosis of hip](FG)

154

1.34

0.76

1.1

6.35

6.29

mmol/l

0.18

154

Non-allergic asthma

1.76

0.76

2.3

1.2

6.28

5.90

mmol/l

—

Deep bite

1.72

0.76

1.2

1.3

5.42

5.81

mmol/l

—

Headache

380

1.22

0.76

1.4

5.64

5.71

mmol/l

0.25

380

Emergency coronary revascularization (for ACS)

220

1.26

0.75

1.1

6.29

6.33

mmol/l

0.09

220

Viral and other specified intestinal infections, including avohilmo

224

0.69

0.75

1.6

1.4

5.48

5.42

mmol/l

0.11

224

Misadventures to patients during surgical and medical care

1.70

0.75

1.3

1.2

5.67

5.98

mmol/l

—

Injuries to the elbow and forearm

414

0.79

0.75

1.4

1.3

5.64

5.78

mmol/l

0.56

414

Codeine

388

0.82

0.75

1.2

1.4

5.85

5.64

mmol/l

0.95

388

Migraine

313

1.24

0.75

1.4

5.37

5.56

mmol/l

0.71

313

Other pulmonary diagnosis

277

1.21

0.74

1.2

1.3

5.88

5.74

mmol/l

0.50

277

Other demyelinating diseases of the central nervous system

2.09

0.74

1.4

6.00

5.67

mmol/l

—

Other specified/unspecified inflammatory spondylopathies

2.09

0.74

1.0

1.3

6.14

5.82

mmol/l

—

Benign neoplasm of brain and other parts of central nervous system

2.09

0.74

1.0

1.3

6.40

5.90

mmol/l

—

Pediculosis, acariasis and other infestations

2.09

0.74

1.2

1.3

5.74

6.13

mmol/l

—

Injury of muscle and tendon at lower leg level

1.67

0.74

1.0

1.2

6.52

6.15

mmol/l

—

Sensorineural hearing loss

238

1.26

0.74

1.2

6.13

6.18

mmol/l

0.12

238

Sequelae of injuries of lower limb

1.84

0.73

1.1

1.2

7.73

5.91

mmol/l

—

Injuries to the thorax

231

0.69

0.73

1.2

1.1

5.66

6.05

mmol/l

0.93

231

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

373

0.81

0.73

1.3

1.4

5.93

5.72

mmol/l

0.82

373

0.81

0.73

1.3

1.4

5.93

5.72

mmol/l

0.82

373

Rheumatoid arthritis, including avohilmo

184

0.65

0.73

1.4

1.2

6.59

5.95

mmol/l

0.31

184

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

141

0.67

0.73

1.0

1.1

6.14

6.33

mmol/l

0.42

141

Malaise and fatigue

237

0.73

1.0

1.3

6.01

5.84

mmol/l

0.61

237

Non-selective monoamine reuptake inhibitors

152

1.39

0.73

1.2

6.34

6.22

mmol/l

0.32

152

Radial styloid tenosynovitis [de Quervain]

2.00

0.72

1.0

1.4

5.56

5.78

mmol/l

—

Intestinal adhesions without obstruction

2.00

0.72

1.4

1.1

5.58

6.20

mmol/l

—

KRA_PSY_EATING, excluding more controls

105

0.57

0.72

1.0

1.4

5.07

5.24

mmol/l

—

105

Eating disorders

106

0.56

0.72

1.0

1.4

5.07

5.40

mmol/l

—

106

Cellulitis

107

0.56

0.72

1.0

1.2

5.72

5.83

mmol/l

—

107

Other specified and unspecified personality disorders

1.61

0.72

1.7

1.3

6.54

5.66

mmol/l

—

Speech therapy

109

0.55

0.72

1.3

1.1

5.95

6.11

mmol/l

—

109

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1.67

0.72

1.3

1.2

6.10

6.20

mmol/l

—

Hypothyroidism (congenital or acquired)

131

1.32

0.72

1.4

1.5

5.66

5.28

mmol/l

2.18

131

Pulmonary heart disease, diseases of pulmonary circulation

117

1.45

0.71

1.0

1.1

6.35

6.17

mmol/l

0.43

117

Twin gestation

1.58

0.71

1.8

1.2

5.53

5.75

mmol/l

—

Benign thyroid growths and nodules

140

1.39

0.71

1.4

1.2

5.78

6.01

mmol/l

0.61

140

Poor fetal growth

151

1.39

0.71

2.0

1.4

5.31

5.36

mmol/l

0.06

151

Diabetes medication

401

1.18

0.71

1.4

1.3

6.72

5.60

mmol/l

8.91

401

Depression or dysthymia

235

1.23

0.70

1.1

1.3

5.99

5.90

mmol/l

0.34

235

Acute lymphadenitis

1.92

0.70

2.0

1.3

5.86

5.82

mmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

1.92

0.70

1.2

5.54

6.09

mmol/l

—

Other neurological diseases

280

1.25

0.70

1.2

6.20

6.01

mmol/l

0.86

280

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1.61

0.70

1.0

1.3

5.16

5.51

mmol/l

0.91

Primary gonarthrosis, bilateral

155

1.35

0.69

1.1

6.34

mmol/l

0.01

155

Hyperlipidaemia, other/unspecified

130

0.62

0.69

1.1

6.18

6.25

mmol/l

—

130

Noninfectious colitis NAS

1.55

0.69

1.7

1.2

5.47

5.82

mmol/l

—

Diseases of salivary glands

186

1.34

0.69

1.3

1.2

6.06

5.82

mmol/l

0.43

186

Strabismus

160

1.37

0.69

1.1

1.2

5.88

5.74

mmol/l

0.26

160

Follow-up examination after treatment for conditions other than malignant neoplasms

199

1.27

0.68

1.6

1.3

5.93

5.76

mmol/l

0.47

199

Other bacterial diseases

382

0.81

0.68

1.1

1.2

6.25

5.95

mmol/l

1.16

382

Hypertensive diseases

249

1.22

0.68

1.3

1.2

6.20

5.86

mmol/l

1.80

249

Hypertension

249

1.22

0.68

1.3

1.2

6.20

5.86

mmol/l

1.80

249

Episcleritis

1.85

0.68

1.2

1.3

6.08

5.81

mmol/l

—

Benign neoplasm: Cerebral meninges

1.85

0.68

1.2

5.76

6.01

mmol/l

—

Other diseases of oesophagus

1.85

0.68

1.2

5.46

6.18

mmol/l

—

Other follicular disorders

1.67

0.68

1.1

1.3

6.03

5.71

mmol/l

—

Trochanteric bursitis

1.67

0.68

1.1

5.94

5.88

mmol/l

—

Early lumbar disc prolapse operation

1.60

0.68

1.3

6.61

5.62

mmol/l

0.47

Effects of foreign body entering through natural orifice

117

0.60

0.67

1.1

1.2

6.06

5.95

mmol/l

—

117

All chronic kidney diseases

209

0.72

0.67

1.0

1.2

6.03

6.02

mmol/l

0.03

209

Symptoms and signs involving cognition, perception, emotional state and behaviour

425

1.18

0.67

1.1

1.3

5.94

5.86

mmol/l

0.28

425

Gout

0.54

0.67

1.2

1.1

6.38

6.34

mmol/l

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1.84

0.67

1.4

1.1

6.34

6.15

mmol/l

—

Sleep disorders (combined)

399

1.16

0.67

1.3

5.84

5.74

mmol/l

0.46

399

Statin medication

224

1.23

0.66

1.1

1.3

6.29

5.64

mmol/l

3.46

224

Endometriosis diagnosis and infertility diagnosis occurring together

0.53

0.66

1.0

1.3

5.84

5.46

mmol/l

—

Vasomotor rhinitis (mode)

1.79

0.66

1.0

1.3

5.92

5.87

mmol/l

—

Heart failure,strict

130

1.34

0.66

1.0

1.1

6.26

6.31

mmol/l

0.10

130

Gout, FINNGEN

0.52

0.66

1.2

1.1

6.38

6.32

mmol/l

—

Lower back pain or/and sciatica

471

1.16

0.65

1.3

5.97

5.76

mmol/l

1.37

471

Excluding asthma or asthma-COPD overlap

277

1.19

0.65

1.2

1.3

5.79

5.74

mmol/l

0.16

277

Oxycodone

131

1.37

0.65

1.2

1.1

6.63

6.15

mmol/l

1.20

131

Bronchitis

455

1.16

0.64

1.3

5.95

5.76

mmol/l

1.07

455

Transport accidents

297

1.23

0.64

1.6

1.3

5.60

5.76

mmol/l

0.57

297

ILD medications: immunosuppressive drugs

377

0.79

0.64

1.3

6.03

5.82

mmol/l

0.27

377

Implicit Sepsis, including avohilmo

369

0.81

0.64

1.3

1.2

6.00

5.98

mmol/l

0.07

369

Atrial fibrillation and flutter

1.45

0.64

1.0

1.1

6.72

6.21

mmol/l

1.32

Irregular menses

338

0.80

0.64

1.3

1.4

5.70

5.51

mmol/l

0.49

338

Complications of medical and surgical care

395

1.21

0.64

1.2

1.3

5.90

5.86

mmol/l

0.11

395

Other osteochondropathies

1.73

0.64

1.8

1.3

5.14

5.90

mmol/l

—

Malignant neoplasm of kidney, except renal pelvis

1.73

0.64

1.0

1.1

6.22

6.23

mmol/l

—

Asthma and allergy, excluding more controls

102

1.45

0.64

1.6

1.4

5.19

5.40

mmol/l

0.84

102

Fracture of forearm

283

0.76

0.63

1.6

1.2

5.51

5.89

mmol/l

2.15

283

Other metabolic disorders

1.55

0.62

1.2

1.3

5.85

5.83

mmol/l

0.03

Medical abortion

262

1.20

0.62

1.3

5.57

5.53

mmol/l

0.13

262

104

0.58

0.61

1.3

5.07

5.54

mmol/l

—

104

Benign neoplasm: Sigmoid colon

1.59

0.61

1.2

1.1

6.09

6.26

mmol/l

—

Haemorrhoids and perianal venous thrombosis

163

1.34

0.61

1.1

1.2

6.48

5.97

mmol/l

1.74

163

Inflammatory diseases of female pelvic organs

374

0.82

0.61

1.4

5.68

5.55

mmol/l

0.46

374

Mood [affective] disorders

459

1.16

0.61

1.2

1.3

6.00

5.76

mmol/l

1.70

459

Cerebral aneurysm, nonruptured

1.67

0.61

1.0

1.2

8.62

6.13

mmol/l

—

Malignant neoplasm of urinary organs

1.67

0.61

1.0

1.1

6.22

6.25

mmol/l

—

Benign neoplasm of meninges

1.67

0.61

1.2

5.76

6.04

mmol/l

—

Other and unspecified injuries of head

1.67

0.61

1.2

5.74

6.13

mmol/l

—

Malignant neoplasm of digestive organs

117

0.65

0.61

1.1

6.15

6.36

mmol/l

—

117

Implicit bacterial Sepsis, including avohilmo

166

0.70

0.61

1.4

1.2

6.41

6.20

mmol/l

0.26

166

Asthma and allergy

103

1.44

0.61

1.6

1.4

5.19

5.40

mmol/l

0.83

103

Endometriosis ASRM stages 3,4

164

0.67

0.61

1.0

1.3

6.00

5.63

mmol/l

0.53

164

Hypokalaemia

1.60

0.61

1.1

6.33

6.08

mmol/l

—

Methotrexate

1.60

0.61

1.0

1.2

5.60

5.87

mmol/l

—

Bacterial pneumonia (organism specified)

180

0.70

0.60

1.4

1.2

6.21

5.94

mmol/l

0.45

180

Insomnia

448

1.16

0.60

1.4

1.3

5.69

5.76

mmol/l

0.29

448

Inguinal hernia

201

0.76

0.60

1.3

1.2

6.14

6.12

mmol/l

0.04

201

Candidiasis, including avohilmo

210

0.71

0.60

1.1

1.3

5.93

5.66

mmol/l

0.66

210

Mood disorders

459

1.16

0.60

1.2

1.3

6.00

5.76

mmol/l

1.70

459

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.60

0.0

1.4

—

5.81

—

Malignant neoplasm of brain, including Hilmo

0.00

0.60

0.0

1.3

—

6.07

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.60

0.0

1.3

—

6.15

—

Diseases of tongue

0.00

0.60

0.0

1.3

—

5.64

—

Injury of other and unspecified intrathoracic organs

0.00

0.60

0.0

1.2

—

6.35

—

Exposure to other and unspecified animate mechanical forces

0.00

0.60

0.0

1.3

—

5.79

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.60

0.0

1.3

—

5.91

—

Golimumab

0.00

0.60

0.0

1.3

—

5.99

—

Cramp and spasm

0.00

0.60

0.0

1.4

—

5.83

—

Foreign body in alimentary tract

0.00

0.60

0.0

1.3

—

5.98

—

Tongue abnormality

0.00

0.60

0.0

1.3

—

6.10

—

Other and unspecified glaucoma

0.00

0.60

0.0

1.2

—

6.19

—

COPD/asthma related infections

373

1.15

0.59

1.2

1.4

5.94

5.72

mmol/l

1.42

373

COPD/asthma/ILD related infections

373

1.15

0.59

1.2

1.4

5.94

5.72

mmol/l

1.42

373

Meniscus derangement

179

1.26

0.59

1.1

1.2

6.24

6.15

mmol/l

0.29

179

Ankylosing spondylitis, strict definition

0.00

0.59

0.0

1.2

—

6.03

—

Convalescence

0.00

0.59

0.0

1.3

—

5.97

—

Calcific tendinitis of shoulder

0.00

0.59

0.0

1.1

—

6.08

—

Ethmoidectomy

1.54

0.59

1.0

1.3

6.89

5.86

mmol/l

—

Lesion of ulnar nerve

1.54

0.59

1.5

1.1

5.71

6.09

mmol/l

—

0.00

0.59

0.0

1.4

—

5.95

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

332

1.22

0.59

1.2

1.4

5.96

5.69

mmol/l

0.97

332

Atrophic disorders of skin

1.53

0.59

1.2

6.55

5.86

mmol/l

0.90

Polyarthrosis

1.50

0.59

1.2

1.1

6.78

6.25

mmol/l

0.25

Coxarthrosis, primary

181

1.28

0.58

1.1

6.33

6.31

mmol/l

0.06

181

Soft tissue disorders

368

1.15

0.58

1.3

1.4

5.87

5.64

mmol/l

1.22

368

Antihypertensive medication - note that there are other indications

269

1.18

0.58

1.3

1.5

5.81

5.31

mmol/l

3.53

269

Pathological resorption of teeth

0.00

0.58

0.0

1.3

—

5.85

—

Memory loss

0.00

0.58

0.0

1.2

—

6.19

—

Other ill-defined and unspecified causes of mortality

0.00

0.58

0.0

1.2

—

6.15

—

Depression

451

1.16

0.58

1.3

5.94

5.75

mmol/l

1.13

451

Implicit bacterial Sepsis

149

0.69

0.58

1.2

1.1

6.62

6.24

mmol/l

0.48

149

Inflammatory bowel disease

185

0.70

0.58

1.4

1.2

5.78

5.80

mmol/l

0.04

185

Other disorders of cornea

1.72

0.57

2.0

1.2

5.85

5.94

mmol/l

—

Use of rivastigmine

1.71

0.57

1.2

1.1

6.05

6.27

mmol/l

—

Diaphragmatic hernia

149

1.34

0.57

1.2

1.1

5.94

6.18

mmol/l

0.54

149

Recurrent or chronic depression

201

1.24

0.57

1.1

1.3

6.14

5.78

mmol/l

1.30

201

Noninflammatory disorders of female genital tract

190

1.22

0.57

1.3

1.5

5.52

5.40

mmol/l

0.49

190

Dermatitis and eczema

455

1.14

0.56

1.3

5.67

5.84

mmol/l

0.86

455

Acne, including avohilmo

214

0.76

0.56

1.5

5.17

5.23

mmol/l

0.20

214

Bacterial infection, other or unspecified, including avohilmo

235

0.77

0.56

1.3

1.2

5.96

6.05

mmol/l

0.21

235

Abnormal weight loss

1.67

0.56

1.2

5.82

5.94

mmol/l

—

Other benign neoplasms of connective and other soft tissue

1.67

0.56

1.2

5.95

5.94

mmol/l

—

Metatarsalgia

1.67

0.56

1.3

5.40

5.76

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

418

0.82

0.56

1.3

1.4

5.62

5.67

mmol/l

0.12

418

Cervical disc disorders

141

1.35

0.56

1.2

6.13

6.17

mmol/l

0.08

141

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.55

0.56

1.0

1.2

6.16

6.31

mmol/l

—

Opioids

391

0.86

0.55

1.2

1.4

5.89

5.64

mmol/l

1.38

391

Rheumatoid arthritis

142

0.69

0.55

1.5

1.2

6.70

6.02

mmol/l

0.30

142

Malignant neoplasm of breast, ER-negative, including Hilmo

0.55

1.4

1.1

5.62

6.11

mmol/l

—

Other peripheral vascular diseases

1.62

0.55

1.0

1.3

6.03

5.82

mmol/l

—

Weight loss

1.62

0.55

1.2

5.82

5.91

mmol/l

—

Abnormalities of gait and mobility

1.62

0.55

1.0

1.2

5.58

6.16

mmol/l

—

Colorectal cancer

0.55

1.2

1.1

6.14

6.28

mmol/l

—

Injuries to the wrist and hand

493

0.86

0.55

1.3

5.66

5.81

mmol/l

0.54

493

Uterine polyps

101

0.69

0.55

1.1

1.3

6.30

5.67

mmol/l

1.52

101

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

303

1.17

0.54

1.1

1.2

7.02

5.73

mmol/l

7.98

303

Other contact dermatitis

1.58

0.54

2.0

1.3

5.20

5.71

mmol/l

—

Other shoulder lesions

1.58

0.54

1.3

5.10

5.83

mmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

1.58

0.54

1.2

5.97

5.96

mmol/l

—

Failed induction of labour

1.50

0.54

1.4

1.2

5.52

5.45

mmol/l

—

Fracture of shoulder and upper arm

159

0.69

0.54

1.3

1.2

5.55

6.03

mmol/l

1.19

159

Multiple gestation

1.50

0.54

1.8

1.2

5.53

5.76

mmol/l

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.48

0.53

1.2

1.3

5.81

5.87

mmol/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

449

0.85

0.53

1.2

1.3

6.13

5.83

mmol/l

1.34

449

Alzheimer’s disease (Late onset), excluding more controls

1.56

0.53

1.2

1.1

6.25

6.48

mmol/l

—

Car occupant injured in other and unspecified transport accidents

125

1.36

0.53

1.8

1.3

5.65

5.64

mmol/l

0.02

125

Otitis media, unspecified

1.49

0.53

1.9

1.3

5.63

5.45

mmol/l

0.22

Skin changes due to chronic exposure to nonionizing radiation

113

1.36

0.53

1.0

1.1

6.25

6.31

mmol/l

0.11

113

Injury of muscle and tendon at hip and thigh level

1.54

0.53

1.0

1.2

6.00

5.98

mmol/l

—

Temporomandibular joint disorders, including avohilmo

381

0.81

0.53

1.4

5.57

5.56

mmol/l

0.03

381

Female infertility, associated with anovulation

108

1.39

0.53

1.6

1.5

5.40

5.22

mmol/l

0.49

108

Other enthesopathy of foot (+metatarsalgia)

1.54

0.53

1.3

5.40

5.85

mmol/l

—

Stomatitis and related lesions

108

1.39

0.53

1.4

1.2

5.78

5.74

mmol/l

0.05

108

Other acute lower respiratory infections

301

0.79

0.52

1.4

1.3

5.79

5.84

mmol/l

0.11

301

Nonorganic sleeping disorders, excluding more controls

158

0.70

0.52

1.8

1.3

5.76

5.52

mmol/l

0.49

158

Visual disturbances

277

1.23

0.52

1.2

6.01

5.90

mmol/l

0.32

277

Fenamates

1.50

0.52

1.7

1.4

5.65

5.55

mmol/l

0.17

Hypertrophy of breast in women and men

117

1.37

0.52

1.2

1.3

6.01

5.80

mmol/l

0.44

117

Eating disorder

0.62

0.52

1.0

1.4

5.07

5.39

mmol/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

386

0.82

0.51

1.5

1.3

5.41

5.66

mmol/l

0.94

386

Iron deficiency anaemia

210

1.26

0.51

1.3

1.2

5.76

5.90

mmol/l

0.43

210

Localized swelling, mass and lump of skin and subcutaneous tissue

169

0.71

0.51

1.2

6.25

5.91

mmol/l

0.77

169

Acne

0.60

0.51

1.7

1.4

5.03

5.38

mmol/l

—

Abnormal serum enzyme levels

113

1.37

0.51

1.1

1.2

6.08

6.29

mmol/l

0.71

113

121

1.34

0.51

1.0

1.1

6.27

6.30

mmol/l

0.06

121

Unspecified fall

276

0.78

0.51

1.3

1.2

5.96

5.92

mmol/l

0.06

276

Disturbances of skin sensation

197

1.27

0.50

1.4

1.3

5.56

5.74

mmol/l

0.52

197

Aplastic and other anaemias

175

0.73

0.50

1.1

1.2

6.44

6.04

mmol/l

2.07

175

Ischemic heart diseases

224

1.20

0.50

1.1

6.31

6.28

mmol/l

0.09

224

Puerperal sepsis

1.39

0.50

1.2

5.66

5.89

mmol/l

—

Other specific joint derangements/joint disorders

356

1.15

0.50

1.2

1.4

6.07

5.64

mmol/l

1.39

356

Myocardial infarction, strict

114

1.30

0.49

1.1

6.45

6.44

mmol/l

0.02

114

Certain infectious and parasitic diseases, including avohilmo

289

0.85

0.49

1.2

1.3

5.71

5.80

mmol/l

0.29

289

Anxiety disorders, excluding more controls

372

1.15

0.49

1.3

5.89

5.76

mmol/l

0.55

372

Explicit Sepsis

214

0.77

0.49

1.1

1.2

6.09

6.02

mmol/l

0.08

214

Other anaemias

167

0.73

0.49

1.1

1.2

6.41

6.04

mmol/l

1.74

167

Other obstructed labour

1.56

0.49

1.3

1.1

5.70

5.75

mmol/l

—

Pilonidal cyst

1.56

0.49

1.3

5.40

5.68

mmol/l

—

Generalized anxiety disorder

155

0.71

0.48

1.2

1.4

5.53

5.40

mmol/l

0.17

155

Abnormalities of heart beat

201

1.25

0.48

1.3

6.08

5.77

mmol/l

0.32

201

Seropositive rheumatoid arthritis, wide

109

0.64

0.48

1.6

1.1

5.87

6.10

mmol/l

—

109

Constipation

352

0.85

0.48

1.2

6.25

5.98

mmol/l

1.02

352

Actinic keratosis

108

1.35

0.48

1.0

1.1

6.33

6.30

mmol/l

0.04

108

Bacterial pneumoniae

166

0.74

0.47

1.4

1.2

6.21

5.97

mmol/l

0.39

166

Diseases of liver

143

0.70

0.47

1.1

1.2

6.42

6.13

mmol/l

—

143

Venous thromboembolism

218

1.24

0.47

1.1

1.2

6.19

6.08

mmol/l

0.30

218

Early lumbar disc prolapse, operated

1.47

0.47

1.3

1.2

6.66

5.63

mmol/l

—

Heart failure, strict

144

1.25

0.47

1.0

1.1

6.26

6.33

mmol/l

0.18

144

Rosacea

1.47

0.47

1.6

1.2

5.23

5.72

mmol/l

—

Diseases of the respiratory system

227

1.17

0.47

1.3

5.76

5.68

mmol/l

0.24

227

Raynaud syndrome

1.46

0.46

1.0

1.4

5.93

5.81

mmol/l

—

Chronic gastritis

1.41

0.46

1.1

6.34

6.17

mmol/l

0.42

Benign neoplasm of colon, rectum, anus and anal canal

222

1.22

0.46

1.1

6.19

6.31

mmol/l

0.34

222

Viral and other specified intestinal infections

161

0.73

0.46

1.8

1.4

5.42

5.45

mmol/l

0.04

161

Depression medications

131

1.23

0.46

1.3

1.5

5.59

5.28

mmol/l

1.57

131

Nontoxic goitre/thyroid nodule

120

1.33

0.46

1.3

1.2

5.94

6.01

mmol/l

0.14

120

Malignant neoplasm of breast, HER-negative

0.62

0.46

1.4

1.1

5.62

6.10

mmol/l

—

Intestinal stricture

118

0.68

0.45

1.4

1.2

5.76

6.21

mmol/l

—

118

Fracture of lumbar spine and pelvis

0.60

0.45

2.0

1.1

6.50

5.96

mmol/l

—

Reimbursement for rheumatic diseases

318

0.81

0.45

1.2

6.23

5.88

mmol/l

0.38

318

Fall on same level

463

0.89

0.45

1.4

1.3

5.72

5.79

mmol/l

0.27

463

Explicit Sepsis, including avohilmo

220

0.78

0.45

1.1

1.2

6.09

6.01

mmol/l

0.10

220

Coronary atherosclerosis

160

1.22

0.44

1.1

6.32

6.39

mmol/l

0.21

160

Any reimbursement code in KELA

261

1.15

0.44

1.4

1.5

5.68

5.43

mmol/l

1.13

261

Hypertrophy of breast

112

1.34

0.44

1.2

1.3

6.01

5.78

mmol/l

0.46

112

Atherosclerosis, excluding cerebral and coronary sclerosis

111

0.71

0.44

1.4

1.1

6.59

6.29

mmol/l

—

111

Selective serotonin reuptake inhibitors

354

1.13

0.44

1.3

5.93

5.80

mmol/l

0.60

354

Pneumonia, organism unspecified

426

0.87

0.44

1.2

1.3

6.07

5.84

mmol/l

0.76

426

Infections of genitourinary tract in pregnancy

1.37

0.44

1.7

1.3

5.33

5.49

mmol/l

—

FESS (DNB20)

1.37

0.44

1.0

1.3

7.09

5.85

mmol/l

—

All kidney diseases

480

0.88

0.44

1.3

5.87

5.78

mmol/l

0.18

480

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

244

1.22

0.44

1.3

1.5

5.84

5.46

mmol/l

1.26

244

Other bacterial diseases, including avohilmo

421

0.87

0.44

1.2

1.3

6.12

5.84

mmol/l

1.60

421

Ovarian dysfunction

1.37

0.43

1.8

1.3

5.92

5.39

mmol/l

0.73

Triptan medication for migraine, min. 3 purchases

357

1.15

0.43

1.4

5.31

5.60

mmol/l

1.58

357

Intestinal infectious diseases, including avohilmo, including avohilmo

464

0.89

0.43

1.3

5.97

5.79

mmol/l

0.84

464

Open wound of wrist and hand

286

0.81

0.43

1.1

1.3

5.88

5.87

mmol/l

0.01

286

Adverse effects, not elsewhere classified

128

0.70

0.43

1.2

1.3

6.09

5.65

mmol/l

—

128

Inflammatory bowel disease, strict (require KELA)

140

0.71

0.43

1.4

1.2

5.75

5.73

mmol/l

—

140

Urinary track infection

274

0.86

0.43

1.2

1.4

5.85

5.47

mmol/l

1.81

274

Pain in thoracic spine

1.41

0.43

1.3

1.2

5.55

5.81

mmol/l

0.53

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1.61

0.43

1.0

1.1

6.22

6.23

mmol/l

—

Diseases of the musculoskeletal system and connective tissue

220

1.16

0.43

1.4

5.65

5.52

mmol/l

0.47

220

Benign neoplasm: Colon

198

1.23

0.43

1.1

6.17

6.31

mmol/l

0.42

198

Other disorders of ear

351

1.14

0.42

1.2

6.18

5.98

mmol/l

1.03

351

Other and unspecified anaemias

163

0.75

0.42

1.1

6.41

6.05

mmol/l

1.68

163

Heart failure and coronary heart disease

1.30

0.42

1.0

1.1

6.30

6.41

mmol/l

0.19

Allergic conjunctivitis

409

0.85

0.42

1.6

1.3

5.45

5.66

mmol/l

0.78

409

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1.40

0.42

1.3

1.2

5.78

6.01

mmol/l

—

Nutritional anaemias

228

1.21

0.42

1.3

1.2

5.80

5.91

mmol/l

0.33

228

Other headache syndromes

266

1.20

0.42

1.3

1.4

5.63

5.71

mmol/l

0.28

266

Other cataract

129

0.75

0.41

1.1

6.46

6.26

mmol/l

0.30

129

Chondropathies

1.43

0.41

1.4

1.2

5.30

5.77

mmol/l

—

Hernia of abdominal wall, postoperative

1.40

0.41

1.2

6.17

6.16

mmol/l

0.01

Acute tubulo-interstitial nephritis

340

0.84

0.41

1.3

6.01

5.78

mmol/l

0.30

340

Other appendicitis

1.52

0.41

1.6

1.2

6.00

5.96

mmol/l

—

Collagenous colitis

1.52

0.41

1.4

1.3

5.98

5.88

mmol/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1.52

0.41

1.2

6.32

5.88

mmol/l

—

Benign neoplasm of major salivary glands

1.52

0.41

1.2

5.54

6.21

mmol/l

—

Malignant neoplasm of cervix uteri

0.00

0.41

0.0

1.5

—

5.73

—

Intentional self-harm by sharp object

0.00

0.41

0.0

1.4

—

5.69

—

Chronic hepatitis, not elsewhere classified

0.00

0.41

0.0

1.3

—

6.11

—

SLE (Finngen)

0.00

0.41

0.0

1.3

—

5.97

—

Follow-up care involving plastic surgery

0.00

0.41

0.0

1.3

—

6.02

—

Hypercalcemia

0.00

0.41

0.0

1.3

—

6.19

—

Malignant neoplasm of ovary

0.00

0.41

0.0

1.3

—

5.93

—

Enterobiasis, including avohilmo

0.00

0.41

0.0

1.4

—

5.38

—

Malignant neoplasm of cervix uteri, including Hilmo

0.00

0.41

0.0

1.4

—

5.72

—

Other salmonella infections

0.00

0.41

0.0

1.3

—

6.11

—

Medial epicondylitis

0.00

0.41

0.0

1.2

—

5.95

—

Early complications of trauma

0.00

0.41

0.0

1.3

—

6.05

—

!Aliquae complicationes praecoces traumatis

0.00

0.41

0.0

1.3

—

6.05

—

Malignant neoplasm, without specification of site, including Hilmo

0.00

0.41

0.0

1.3

—

6.13

—

Use of galantamine

0.00

0.41

0.0

1.1

—

6.26

—

Malignant neoplasm of bladder

0.00

0.41

0.0

1.1

—

6.31

—

Sacrococcygeal disorders, not elsewhere classified

0.00

0.40

0.0

1.4

—

5.84

—

Need for other prophylactic measures

0.00

0.40

0.0

1.4

—

6.02

—

Extracorporeal dialysis

0.00

0.40

0.0

1.3

—

6.22

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.40

0.0

1.2

—

6.29

—

Disorders of calcium metabolism

0.00

0.40

0.0

1.2

—

6.11

—

Infections with a predominantly sexual mode of transmission

249

0.80

0.40

1.4

5.42

5.48

mmol/l

0.15

249

All-cause Heart Failure

141

1.23

0.40

1.0

1.1

6.27

6.33

mmol/l

0.15

141

Divergent concomitant strabismus

1.47

0.40

1.0

1.2

6.04

5.81

mmol/l

—

IBD patients in KELA-register

138

0.72

0.40

1.4

1.2

5.75

5.76

mmol/l

—

138

Sleep disorders

448

1.12

0.40

1.4

1.3

5.70

5.79

mmol/l

0.38

448

Ulcerative enterocolitis

0.00

0.40

0.0

1.3

—

5.89

—

Benign neoplasm: Skin, unspecified

0.00

0.40

0.0

1.4

—

5.85

—

Ischaemic heart disease, wide definition

204

1.18

0.39

1.1

6.30

6.37

mmol/l

0.21

204

Second line medication for Crohn's disease

346

0.84

0.39

1.2

6.12

5.86

mmol/l

0.28

346

Other hearing loss

0.69

0.39

1.4

1.1

6.44

6.12

mmol/l

—

Viral warts

1.31

0.39

1.1

1.3

5.77

5.68

mmol/l

—

Seropositive rheumatoid arthritis

101

0.69

0.39

1.6

1.2

5.87

6.04

mmol/l

—

101

Other female pelvic inflammatory diseases

101

0.69

0.39

1.4

1.2

5.77

5.72

mmol/l

—

101

Somatoform disorder

103

0.68

0.39

1.7

1.2

5.17

5.64

mmol/l

—

103

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

104

0.67

0.39

1.6

1.1

5.87

6.09

mmol/l

—

104

Other and unspecified rosacea

1.43

0.39

2.0

1.2

5.14

5.85

mmol/l

—

Polymyalgia rheumatica

1.43

0.39

1.0

1.1

6.34

6.25

mmol/l

—

Other/unspecified seropositive rheumatoid arthritis

105

0.67

0.39

1.6

1.1

5.87

6.10

mmol/l

—

105

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

0.39

0.0

1.3

—

6.00

—

Injuries involving multiple body regions

0.00

0.39

0.0

1.3

—

5.93

—

Toxic effect of contact with venomous animals

0.00

0.39

0.0

1.4

—

5.93

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

0.39

0.0

1.3

—

6.31

—

Other disorders of pigmentation

0.00

0.39

0.0

1.3

—

6.06

—

Artificial opening status

0.00

0.39

0.0

1.2

—

6.29

—

Other aneurysm

0.00

0.39

0.0

1.3

—

6.24

—

Sequelae of other external causes

0.00

0.39

0.0

1.3

—

5.99

—

Non-small cell lung cancer, adenocarcinoma

0.00

0.39

0.0

1.1

—

6.41

—

Visual impairment including blindness (binocular or monocular)

0.00

0.39

0.0

1.3

—

6.12

—

Nonorganic sleeping disorders

148

0.74

0.38

1.8

1.3

5.76

5.62

mmol/l

0.26

148

Hard cardiovascular diseases

235

1.16

0.38

1.1

6.45

6.18

mmol/l

0.55

235

Chronic sinusitis

269

0.82

0.38

1.1

1.3

6.28

5.83

mmol/l

0.44

269

Visual disturbances and blindness

288

1.18

0.38

1.2

6.01

5.90

mmol/l

0.29

288

Persons encountering health services for examination and investigation

218

1.15

0.38

1.2

1.3

5.61

5.83

mmol/l

0.97

218

Use of memantine

1.34

0.38

1.1

6.17

6.21

mmol/l

—

Use of other anti-dementia drugs

1.34

0.38

1.1

6.17

6.21

mmol/l

—

Renal tubulo-interstitial diseases

433

0.88

0.38

1.3

5.91

5.81

mmol/l

0.17

433

Atopic dermatitis, strict definition

237

1.20

0.38

1.4

5.31

5.49

mmol/l

0.74

237

All anxiety disorders

383

1.13

0.38

1.3

1.4

5.78

5.67

mmol/l

0.36

383

Substance abuse, excluding more controls

306

0.85

0.37

1.2

1.3

6.17

5.84

mmol/l

1.68

306

Other condition

1.32

0.37

1.3

1.2

5.62

5.79

mmol/l

—

Chronic kidney disease

107

0.72

0.37

1.0

1.1

6.17

6.22

mmol/l

—

107

Dislocation, sprain and strain of joints and ligaments at neck level

112

0.71

0.37

1.4

1.3

5.56

5.61

mmol/l

—

112

Bacterial, viral and other infectious agents

1.35

0.37

1.2

1.3

5.14

5.85

mmol/l

—

DVT of lower extremities

1.30

0.37

1.3

1.1

6.02

6.07

mmol/l

—

Female infertility

178

1.18

0.37

1.4

1.5

5.65

5.37

mmol/l

0.86

178

Abdominal and pelvic pain

352

1.11

0.36

1.3

5.83

5.78

mmol/l

0.20

352

Polycystic ovarian syndrome, broad definition

143

1.26

0.36

1.7

1.4

5.46

5.32

mmol/l

0.29

143

Dislocation, sprain and strain of joints and ligaments of knee

397

1.14

0.36

1.2

1.3

6.18

5.73

mmol/l

1.14

397

Infectious mononucleosis

1.29

0.36

1.6

1.3

5.28

5.47

mmol/l

—

Infectious mononucleosis, including avohilmo

1.29

0.36

1.6

1.3

5.28

5.47

mmol/l

—

Family history of malignant neoplasm

1.29

0.36

1.6

1.2

5.36

5.65

mmol/l

—

Anxiety (asthma-related co-morbidities)

362

1.13

0.36

1.3

1.4

5.81

5.65

mmol/l

0.60

362

Propionic acid derivatives

1.28

0.36

1.3

1.4

5.80

5.55

mmol/l

0.71

Neoplasms

354

0.89

0.36

1.3

1.4

5.58

5.64

mmol/l

0.19

354

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

379

0.88

0.36

1.5

1.2

6.07

5.97

mmol/l

0.31

379

Conjunctivitis

437

1.12

0.36

1.5

1.3

5.83

5.69

mmol/l

0.30

437

General examination and investigation of persons without complaint and reported diagnosis

218

0.86

0.36

1.3

6.08

5.83

mmol/l

0.78

218

Other disorders of fluid, electrolyte and acid-base balance

118

1.28

0.36

1.1

1.2

6.28

6.17

mmol/l

0.23

118

Fall on and from stairs and steps

146

0.75

0.36

1.4

1.2

5.77

5.89

mmol/l

0.11

146

Disorders of psychological development

0.63

0.35

1.6

1.4

6.12

5.35

mmol/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1.43

0.35

1.0

1.3

6.28

5.20

mmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

1.43

0.35

2.2

1.3

6.57

5.55

mmol/l

—

Acute laryngitis and tracheitis

1.35

0.35

1.7

1.3

5.62

5.44

mmol/l

0.40

Pain, not elsewhere classified

179

0.78

0.35

1.3

5.78

5.76

mmol/l

0.02

179

Injuries to the hip and thigh

200

0.81

0.35

1.1

1.2

6.05

6.02

mmol/l

0.05

200

Other diseases of liver

0.62

0.35

1.0

1.2

6.58

6.08

mmol/l

—

COPD, early/later onset

141

0.77

0.35

1.1

6.18

6.33

mmol/l

0.46

141

Deforming dorsopathies

153

1.24

0.35

1.3

1.2

6.17

5.79

mmol/l

1.15

153

Hernia

376

0.88

0.35

1.3

1.2

6.01

5.96

mmol/l

0.12

376

Retinal detachment with retinal break

1.40

0.35

1.2

1.1

6.57

6.22

mmol/l

—

Autoimmune diseases

432

0.90

0.35

1.4

1.3

5.94

5.77

mmol/l

0.47

432

Chronic diseases of tonsils and adenoids

361

1.12

0.34

1.3

5.92

5.75

mmol/l

0.39

361

Polycystic ovarian syndrome

1.37

0.34

2.1

1.3

5.42

5.35

mmol/l

—

Sarcoidosis

1.36

0.34

1.0

1.1

6.52

6.17

mmol/l

—

Secondary uncertain malignant neoplasm

1.36

0.34

1.0

1.1

5.88

6.26

mmol/l

—

Continuous positive airway pressure

1.35

0.34

1.0

1.1

6.00

6.02

mmol/l

—

Falls/tendency to fall

415

0.90

0.34

1.5

1.3

5.90

5.74

mmol/l

0.41

415

Internal derangement of knee

216

1.19

0.33

1.2

5.75

5.94

mmol/l

0.59

216

Other disorders of the genitourinary system

1.33

0.33

1.2

1.1

6.62

6.10

mmol/l

—

Other bursopathies

1.30

0.33

1.2

6.23

6.15

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.70

0.33

1.2

1.3

5.52

5.41

mmol/l

—

Tonsillectomy and adenotomy

321

1.13

0.33

1.5

1.4

5.44

5.56

mmol/l

0.51

321

COPD, hospital admissions

140

0.78

0.33

1.1

6.18

6.33

mmol/l

0.46

140

Disorders of skin appendages

357

1.14

0.33

1.4

5.73

5.67

mmol/l

0.16

357

L04AX Other immunosuppressants

328

0.85

0.32

1.2

6.18

5.89

mmol/l

0.31

328

Mental and behavioural disorders due to psychoactive substance use

330

0.86

0.32

1.2

6.17

5.93

mmol/l

1.12

330

Myopia

0.67

0.32

1.2

1.3

6.17

5.55

mmol/l

—

Disorders of lacrimal system

238

0.83

0.32

1.2

6.00

5.90

mmol/l

0.22

238

Other disorders of conjunctiva

1.28

0.32

1.3

1.2

6.50

6.08

mmol/l

—

Hyperkinetic disorders, excluding more controls

144

0.78

0.32

1.4

1.5

5.39

5.18

mmol/l

0.29

144

Gastrointestinal diseases

231

1.13

0.32

1.3

5.70

5.61

mmol/l

0.30

231

Senile cataract

161

1.17

0.31

1.0

1.1

6.26

6.38

mmol/l

0.36

161

Other fall from one level to another

119

1.26

0.31

1.7

1.2

6.01

5.76

mmol/l

0.42

119

Cystitis

365

0.90

0.31

1.2

1.4

5.93

5.62

mmol/l

1.55

365

Gingivitis and periodontal diseases

322

1.11

0.31

1.2

1.3

5.88

5.81

mmol/l

0.25

322

Alzheimer disease, excluding more controls

1.33

0.31

1.1

6.23

6.52

mmol/l

—

Allergic rhinitis

227

0.83

0.31

1.3

1.4

5.86

5.60

mmol/l

0.48

227

Other diseases of anus and rectum

142

0.77

0.31

1.4

1.2

6.02

5.94

mmol/l

0.10

142

Allergic urticaria

1.35

0.31

1.1

1.3

5.57

5.65

mmol/l

—

Female infertility, cervical, vaginal, other or unspecified origin

176

1.16

0.31

1.3

1.5

5.67

5.37

mmol/l

0.84

176

Dentofacial anomalies [including malocclusion]

421

0.89

0.31

1.3

1.4

5.58

5.70

mmol/l

0.48

421

Demyelinating diseases of the central nervous system

1.32

0.30

1.3

5.54

5.73

mmol/l

—

Hallux rigidus

1.32

0.30

1.1

6.37

6.34

mmol/l

—

Congenital malformations and deformations of the musculoskeletal system

1.31

0.30

1.0

1.3

5.20

5.53

mmol/l

—

Endometriosis ASRM stages 1,2

142

0.77

0.30

1.4

1.3

5.37

5.62

mmol/l

0.50

142

Functional dyspepsia

147

1.22

0.30

1.3

1.2

5.85

5.87

mmol/l

0.04

147

AV-block

1.30

0.30

1.0

1.2

6.27

6.29

mmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

100

0.70

0.30

1.3

1.2

5.57

5.70

mmol/l

—

100

Fracture of skull and facial bones

100

0.70

0.30

1.4

1.2

6.20

5.95

mmol/l

—

100

Benign leiomyoma with endometriosis

1.30

0.30

1.1

1.2

6.23

6.17

mmol/l

—

Special screening examination for other diseases and disorders

1.30

0.30

1.6

1.2

6.19

5.93

mmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.33

0.30

1.2

6.32

6.30

mmol/l

—

Sequelae of external causes of morbidity and mortality

120

1.25

0.30

1.3

1.2

5.97

5.96

mmol/l

0.01

120

Use of pramipexole

1.31

0.30

1.2

1.1

6.03

6.19

mmol/l

0.24

Iron deficiency anaemia secondary to blood loss (chronic)

1.27

0.30

1.3

1.2

5.87

6.07

mmol/l

—

Non-rheumatic valve diseases

131

1.20

0.29

1.1

1.2

5.84

6.31

mmol/l

1.71

131

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

231

1.17

0.29

1.4

5.63

5.51

mmol/l

0.31

231

Bacterial pneumonia, not elsewhere classified

153

0.80

0.29

1.4

1.2

6.21

5.98

mmol/l

0.38

153

Exposure to other specified factors

496

0.90

0.29

1.2

1.3

5.83

5.80

mmol/l

0.10

496

Other strabismus

138

1.23

0.29

1.2

1.3

5.94

5.66

mmol/l

0.43

138

Chronic periodontitis, including avohilmo

416

0.90

0.29

1.2

1.3

5.98

5.90

mmol/l

0.26

416

Medical observation and evaluation for suspected diseases and conditions

218

1.13

0.29

1.2

1.3

5.97

5.83

mmol/l

0.41

218

Otitis externa

130

0.77

0.29

1.3

1.2

6.08

5.79

mmol/l

—

130

Suicide or other Intentional self-harm

152

0.79

0.29

1.3

5.88

5.73

mmol/l

0.29

152

Atopic dermatitis, strict definition with reimbursement

240

1.16

0.29

1.4

5.31

5.51

mmol/l

0.80

240

Diseases of middle ear and mastoid

350

1.12

0.29

1.5

1.4

5.55

5.60

mmol/l

0.14

350

Hyperparathyroidism

1.24

0.29

1.1

6.14

6.12

mmol/l

—

Otitis externa, unspecified

1.23

0.29

1.3

1.2

6.23

5.81

mmol/l

—

Thyrotoxicosis, other and/or unspecified

109

0.73

0.29

1.1

1.2

5.65

5.74

mmol/l

—

109

Mouth breathing

185

1.19

0.28

1.1

1.2

6.45

6.07

mmol/l

1.18

185

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

464

0.91

0.28

1.3

6.00

5.78

mmol/l

0.94

464

Ulcerative colitis

140

0.79

0.28

1.4

1.2

5.63

5.84

mmol/l

0.38

140

Benign neoplasm: Rectum

1.27

0.27

1.1

1.2

6.50

6.24

mmol/l

—

Sciatica+with lumbago

264

1.14

0.27

1.3

1.2

5.98

5.84

mmol/l

0.46

264

Obstructed labour due to maternal pelvic abnormality

1.25

0.27

1.3

1.1

6.15

6.08

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

406

0.90

0.27

1.2

1.3

6.13

5.88

mmol/l

1.42

406

Anxiety disorders

446

1.09

0.27

1.4

1.3

5.85

5.77

mmol/l

0.29

446

All dysplastic lesions of the cervix uteri, vagina or vulva

273

1.14

0.27

1.5

1.4

5.42

5.47

mmol/l

0.13

273

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.31

0.27

1.4

1.2

5.45

5.69

mmol/l

—

Other arthritis (FG)

168

1.19

0.27

1.1

1.2

6.74

5.91

mmol/l

0.86

168

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

416

0.91

0.27

1.3

5.95

5.88

mmol/l

0.23

416

Disorders of conjunctiva

460

1.09

0.27

1.5

1.3

5.88

5.72

mmol/l

0.37

460

Myalgia

150

0.80

0.27

1.3

5.79

5.63

mmol/l

0.22

150

Non-ischemic cardiomyopathy

1.26

0.26

1.1

1.2

6.35

6.22

mmol/l

0.37

Herpesviral [herpes simplex] infections, including avohilmo

193

0.83

0.26

1.1

1.3

5.58

5.64

mmol/l

0.11

193

Injuries to the knee and lower leg

461

1.08

0.26

1.2

1.3

6.02

5.74

mmol/l

1.14

461

Valvular heart disease excluding rheumatic fever

133

1.18

0.26

1.1

1.2

5.84

6.29

mmol/l

1.66

133

First line medication for Crohn's disease

449

0.92

0.26

1.3

1.4

5.99

5.71

mmol/l

0.87

449

Hypothyroidism, strict autoimmune

371

1.10

0.26

1.2

1.4

5.80

5.67

mmol/l

0.64

371

Status post-ami

0.66

0.26

1.0

1.2

6.28

6.33

mmol/l

—

Scabies, including avohilmo

1.26

0.26

1.4

1.3

5.90

5.54

mmol/l

0.49

Benign neoplasm of ovary

0.70

0.26

1.4

1.2

5.66

6.02

mmol/l

—

Other superficial mycoses, including avohilmo

0.69

0.26

1.6

1.3

5.00

5.57

mmol/l

—

Acne vulgaris

0.68

0.26

1.8

1.4

4.98

5.30

mmol/l

—

Caries of dentine

1.28

0.25

1.2

1.3

6.31

5.80

mmol/l

0.49

severe traumatic brain injury, does not include concussion

0.67

0.25

1.2

5.88

6.17

mmol/l

—

Keratitis

203

0.84

0.25

1.4

1.2

6.11

5.85

mmol/l

0.62

203

Acute pancreatitis (for exclusion)

1.25

0.25

1.0

1.1

7.01

6.09

mmol/l

—

Coxarthrosis, primary, with hip surgery

148

1.19

0.25

1.1

6.51

6.32

mmol/l

0.47

148

Infections, IBD-co-morbidities

1.22

0.25

1.1

1.3

6.02

5.59

mmol/l

—

Benign neoplasm: Rectum, anus and anal canal

1.23

0.25

1.2

6.39

6.20

mmol/l

—

Degeneration of macula and posterior pole

123

1.19

0.25

1.1

6.38

6.27

mmol/l

0.30

123

Alcohol abuse, main dg, excluding more controls

1.22

0.25

1.1

5.90

5.79

mmol/l

—

Acute pancreatitis

1.22

0.25

1.0

1.2

7.01

6.10

mmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1.19

0.25

1.3

1.1

6.38

6.14

mmol/l

—

Pain in throat and chest

351

0.91

0.25

1.1

1.3

6.04

5.70

mmol/l

1.57

351

Kela-code for severe mental illness

207

1.16

0.25

1.3

1.2

6.37

5.82

mmol/l

3.00

207

Alcohol abuse, main dg

1.20

0.25

1.1

1.2

5.90

5.77

mmol/l

—

Dorsopathies

365

1.08

0.24

1.4

5.77

5.65

mmol/l

0.52

365

Other menopausal disorders

0.78

0.24

1.6

1.3

5.71

5.85

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

191

0.84

0.24

1.5

1.3

5.59

5.76

mmol/l

0.40

191

COPD related to multimorbidity

116

0.80

0.24

1.0

1.1

6.23

6.29

mmol/l

0.15

116

Other diseases of intestines

451

0.93

0.24

1.2

1.4

6.05

5.70

mmol/l

2.22

451

Codeine or tramadol medication

451

0.93

0.24

1.2

1.4

6.08

5.71

mmol/l

1.42

451

Presence of cardiac and vascular implants and grafts

111

1.19

0.24

1.1

6.11

6.39

mmol/l

0.94

111

Early onset COPD

0.71

0.24

1.2

6.15

6.30

mmol/l

—

Neurotic, stress-related and somatoform disorders

445

1.08

0.24

1.4

1.3

5.83

5.76

mmol/l

0.25

445

Diseases of male genital organs

1.18

0.24

1.1

6.14

6.54

mmol/l

1.60

Dementia in Alzheimer disease

1.35

0.23

1.0

1.1

6.52

6.26

mmol/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

115

1.22

0.23

1.3

1.2

5.65

5.78

mmol/l

0.15

115

Disorders of vitreous body

198

1.15

0.23

1.0

1.1

6.36

6.22

mmol/l

0.30

198

Thyroiditis

1.32

0.23

1.4

1.3

5.64

5.82

mmol/l

—

Other and unspecified local infections of skin and subcutaneous tissue

1.32

0.23

1.6

1.3

5.66

5.97

mmol/l

—

Contact with machinery

1.32

0.23

1.0

1.1

5.86

6.28

mmol/l

—

Benign neoplasm of mouth and pharynx

1.32

0.23

1.6

1.2

5.86

5.96

mmol/l

—

Malignant neoplasm of urinary organs, including Hilmo

1.32

0.23

1.0

1.1

6.22

6.24

mmol/l

—

Postmenopausal bleeding

1.26

0.23

1.1

1.2

6.23

6.18

mmol/l

0.06

Used for control exclusion in common control thyroid runs

402

0.93

0.23

1.3

6.01

5.76

mmol/l

0.82

402

ILD, hospital admissions

1.28

0.23

1.4

1.1

6.34

6.19

mmol/l

—

Other interstitial pulmonary diseases

1.28

0.23

1.4

1.1

6.34

6.19

mmol/l

—

Interstitial lung disease

1.28

0.23

1.4

1.1

6.34

6.19

mmol/l

—

Interstitial lung disease endpoints

1.28

0.23

1.4

1.1

6.34

6.19

mmol/l

—

Erosion of teeth , including avohilmo

200

0.85

0.22

1.3

5.68

5.66

mmol/l

0.03

200

Superficial injury of abdomen, lower back and pelvis

1.25

0.22

1.6

1.2

5.43

5.68

mmol/l

0.43

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.77

0.22

1.3

1.2

5.57

5.71

mmol/l

—

Bacterial, viral and other infectious agents, including avohilmo

1.25

0.22

1.2

1.3

5.14

5.80

mmol/l

—

Achilles tendinitis

1.25

0.22

1.2

5.68

6.16

mmol/l

—

Vasomotor and allergic rhinitis

278

0.88

0.22

1.2

1.4

5.89

5.63

mmol/l

0.68

278

Ganglion

125

1.20

0.22

1.2

6.23

5.72

mmol/l

0.91

125

Postpartum hemorraghe, parous women as controls

278

1.11

0.22

1.4

1.5

5.16

5.38

mmol/l

1.16

278

Thyrotoxicosis with diffuse goitre

1.27

0.22

1.2

1.3

5.80

5.75

mmol/l

—

Ulcerative colitis (strict definition, require KELA)

0.74

0.22

1.3

1.2

5.57

5.70

mmol/l

—

Spondyloarthritis

0.74

0.22

1.0

1.2

6.24

5.75

mmol/l

—

Paralytic ileus and intestinal obstruction

0.74

0.22

1.3

1.1

5.70

6.15

mmol/l

—

Acute appendicitis

442

1.09

0.22

1.4

1.3

5.78

5.83

mmol/l

0.16

442

Other noninfective gastroenteritis and colitis

125

1.20

0.22

1.5

1.2

5.54

5.85

mmol/l

0.80

125

Concussion

265

1.11

0.22

1.5

1.4

5.72

5.68

mmol/l

0.11

265

Poisoning by medicine

146

0.82

0.22

1.2

1.3

6.05

5.65

mmol/l

1.03

146

Other local infections of skin and subcutaneous tissue

1.22

0.22

1.6

1.3

5.66

5.98

mmol/l

—

Non-Hodgkin lymphoma, all, including Hilmo

1.22

0.22

1.0

1.1

5.86

6.34

mmol/l

—

Subjective visual disturbances

144

1.18

0.22

1.2

5.91

5.87

mmol/l

0.06

144

Diabetes, insulin treatment (Kela reimbursement)

346

1.08

0.21

1.1

1.2

6.98

5.81

mmol/l

7.45

346

Arthrosis

208

1.11

0.21

1.2

6.45

6.02

mmol/l

0.84

208

Acute appendicitis, no complications

379

1.10

0.21

1.5

1.3

5.74

5.81

mmol/l

0.19

379

Lack of expected normal physiological development

0.00

0.21

0.0

1.3

—

5.37

—

Pediculosis, acariasis and other infestations, including avohilmo

107

1.22

0.21

1.4

1.2

5.94

5.63

mmol/l

0.45

107

Mental and behavioural disorders due to alcohol

270

0.88

0.21

1.2

6.15

5.99

mmol/l

0.47

270

Dermatographic urticaria

1.19

0.21

1.4

1.3

5.64

5.63

mmol/l

—

Endometriosis of rectovaginal septum and vagina

1.19

0.21

1.0

1.3

5.98

5.65

mmol/l

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.21

0.0

1.1

—

6.20

—

Hydatidiform mole

0.00

0.21

0.0

1.2

—

5.83

—

Other specified/unspecified deforming dorsopathies

0.00

0.21

0.0

1.4

—

6.14

—

Other protozoal intestinal diseases, including avohilmo

0.00

0.21

0.0

1.5

—

5.80

—

Other and unspecified nail disorders

0.00

0.21

0.0

1.4

—

6.34

—

Benign neoplasm: Liver

0.00

0.21

0.0

1.4

—

5.79

—

Other articular cartilage disorders

0.00

0.21

0.0

1.2

—

6.12

—

Benign neoplasm: Duodenum

0.00

0.21

0.0

1.2

—

6.21

—

Exposure to other specified electric current

0.00

0.21

0.0

1.4

—

5.87

—

Mumps

0.00

0.21

0.0

1.4

—

6.26

—

Polycystic kidney disease

0.00

0.21

0.0

1.4

—

6.13

—

Other and unspecified diseases of blood and blood-forming organs

0.00

0.21

0.0

1.5

—

6.23

—

Contact with sharp object, undetermined intent

0.00

0.21

0.0

1.4

—

6.01

—

Mumps, including avohilmo

0.00

0.21

0.0

1.4

—

6.26

—

Syphilis

0.00

0.21

0.0

1.4

—

6.15

—

Syphilis, including avohilmo

0.00

0.21

0.0

1.4

—

6.15

—

Disorders of globe

0.00

0.21

0.0

1.3

—

6.26

—

Unspecified event, undetermined intent

0.00

0.21

0.0

1.6

—

6.05

—

Benign neoplasm: Tongue

0.00

0.21

0.0

1.4

—

6.28

—

Benign neoplasm: Cranial nerves

0.00

0.21

0.0

1.5

—

6.07

—

Other and unspecified epidermal thickening

0.00

0.21

0.0

1.4

—

6.14

—

Inguinal of femoral hernia, unilateral

0.00

0.21

0.0

1.3

—

6.17

—

Femoral hernia, unilateral

0.00

0.21

0.0

1.3

—

6.17

—

Inguinal hernia, unilateral

0.00

0.21

0.0

1.3

—

6.17

—

Systemic lupus erythematosus, unspecified

0.00

0.21

0.0

1.4

—

6.21

—

Chorioretinal inflammation

0.00

0.21

0.0

1.4

—

6.12

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

0.21

0.0

1.4

—

6.17

—

Certain zoonotic bacterial diseases, including avohilmo

0.00

0.21

0.0

1.4

—

6.15

—

Adenocarcinoma of pancreas

0.00

0.21

0.0

1.4

—

6.23

—

Sequelae of injuries of neck and trunk

0.00

0.21

0.0

1.4

—

6.28

—

Myelodysplastic syndrome, including Hilmo

0.00

0.21

0.0

1.3

—

6.01

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

0.21

0.0

1.4

—

6.17

—

Pedestrian injured in collision with pedal cycle

0.00

0.21

0.0

1.5

—

6.08

—

Cystic kidney disease

0.00

0.21

0.0

1.4

—

6.13

—

Hypogonadotropic hypogonadism

0.00

0.21

0.0

1.2

—

6.32

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.21

0.0

1.3

—

6.06

—

Cystic kidney disease, including avohilmo

0.00

0.21

0.0

1.4

—

6.11

—

Hypoparathyroidism

0.00

0.21

0.0

1.4

—

6.34

—

Giant cell arteritis with polymyalgia rheumatica

0.00

0.21

0.0

1.2

—

6.18

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.21

0.0

1.4

—

6.32

—

Unspecified chronic bronchitis

0.00

0.21

0.0

1.4

—

6.17

—

Dialysis

0.00

0.21

0.0

1.5

—

6.11

—

Vascular diseases of the intestine

0.00

0.21

0.0

1.4

—

6.13

—

Follicular lymphoma, hilmo

0.00

0.21

0.0

1.5

—

6.19

—

Diffuse brain injury

0.00

0.21

0.0

1.0

—

6.09

—

Attention to artificial openings

0.00

0.21

0.0

1.4

—

6.14

—

Respiratory tuberculosis, not confirmed

0.00

0.21

0.0

1.2

—

6.16

—

Neovascular glaucoma

0.00

0.21

0.0

1.4

—

6.13

—

Respiratory tuberculosis, not confirmed, including avohilmo

0.00

0.21

0.0

1.2

—

6.16

—

Melanoma in situ

0.00

0.21

0.0

1.3

—

6.18

—

Primary angle-closure glaucoma

0.00

0.21

0.0

1.2

—

6.30

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.21

0.0

1.4

—

6.25

—

Dementia in other diseases classified elsewhere

0.00

0.21

0.0

1.2

—

6.03

—

Degenerative diseases of the nervous system

0.76

0.21

1.1

6.31

6.21

mmol/l

—

Cutaneous lupus erythematosus

0.00

0.21

0.0

1.3

—

6.19

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.21

0.0

1.3

—

5.93

—

Routine general health check-up of defined subpopulation

0.00

0.21

0.0

1.2

—

6.07

—

Benign neoplasm: Pancreas

0.00

0.21

0.0

1.4

—

6.04

—

Campylobacter enteritis

0.00

0.21

0.0

1.3

—

6.19

—

Anisometropia and aniseikonia

0.00

0.21

0.0

1.3

—

6.26

—

Gonococcal infection

0.00

0.21

0.0

1.4

—

6.15

—

Open wound of hip and thigh

0.00

0.21

0.0

1.3

—

6.08

—

Other specified and unspecified retinal disorders

0.00

0.21

0.0

1.2

—

6.15

—

Endocarditis

0.00

0.21

0.0

1.3

—

6.27

—

Simple and mucopurulent chronic bronchitis

0.00

0.21

0.0

1.4

—

6.11

—

Laparoscopic right hemicolectomy

0.00

0.21

0.0

1.3

—

6.17

—

Other joint disorders

359

1.07

0.21

1.2

1.4

5.74

5.65

mmol/l

0.30

359

Acute alcohol intoxication, ICD10

101

0.79

0.21

1.1

1.2

5.90

5.91

mmol/l

—

101

Unspecified haematuria

125

1.17

0.21

1.2

1.1

6.31

6.24

mmol/l

0.11

125

Focal epilepsy

103

0.78

0.21

1.1

1.2

5.89

5.81

mmol/l

—

103

Unspecified/other endometriosis

1.24

0.21

1.1

1.4

5.27

5.35

mmol/l

0.13

Brachial plexus disorders

1.16

0.21

1.2

5.66

5.81

mmol/l

—

Open wound of forearm

1.16

0.21

1.4

1.1

5.84

5.82

mmol/l

—

Other and unspecified visual disturbances

1.16

0.21

1.2

6.12

5.92

mmol/l

—

Umbilical hernia

145

0.83

0.21

1.3

1.2

5.96

6.05

mmol/l

0.11

145

Seronegative juvenile rheumatoid arthritis

0.00

0.21

0.0

1.4

—

5.62

—

Other superficial mycoses

0.00

0.21

0.0

1.4

—

5.95

—

Procedures for purposes other than remedying health state

0.00

0.21

0.0

1.5

—

5.96

—

Other and unspecified disease of Bartholin gland

0.00

0.21

0.0

1.4

—

5.97

—

Benign neoplasm: Liver/bile ducts

0.00

0.21

0.0

1.3

—

5.85

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.21

0.0

1.5

—

5.69

—

Other and unspecified corneal deformities and disorders

0.00

0.21

0.0

1.3

—

6.10

—

SLE, ICD10

0.00

0.21

0.0

1.3

—

6.20

—

SLE, strict definition

0.00

0.21

0.0

1.3

—

6.20

—

Vertical strabismus

0.00

0.21

0.0

1.4

—

6.08

—

Gonococcal infection, including avohilmo

0.00

0.21

0.0

1.4

—

6.18

—

Other deformities of toe(s)

0.00

0.21

0.0

1.2

—

6.06

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.21

0.0

1.4

—

6.18

—

Preparatory care for dialysis

0.00

0.21

0.0

1.4

—

6.22

—

Glaucoma secondary to other eye disorders

0.00

0.21

0.0

1.4

—

6.22

—

Pneumonia due to Streptococcus pneumoniae

0.00

0.21

0.0

1.3

—

6.31

—

Other diseases of gallbladder

0.00

0.21

0.0

1.5

—

6.05

—

Respiratory tuberculosis, confirmed and not-confirmed

0.00

0.21

0.0

1.3

—

6.05

—

Respiratory tuberculosis

0.00

0.21

0.0

1.3

—

6.05

—

Fracture of lower leg, including ankle

298

0.89

0.20

1.3

1.2

6.24

5.91

mmol/l

0.38

298

Cerebrovascular diseases (FINNGEN)

1.19

0.20

1.1

1.2

6.75

6.10

mmol/l

0.44

Other and unspecified disorders of vitreous body

160

1.16

0.20

1.1

6.19

6.24

mmol/l

0.08

160

Acute appendicitis, with complications

1.25

0.20

1.2

1.1

5.93

6.08

mmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

238

0.87

0.20

1.2

6.29

6.08

mmol/l

0.71

238

Osteopathies and chondropathies

271

1.11

0.20

1.3

1.2

5.85

5.98

mmol/l

0.36

271

Any dementia

0.78

0.20

1.1

6.31

6.23

mmol/l

—

5-aminosalicylic acid

123

0.81

0.20

1.3

1.2

5.69

5.76

mmol/l

—

123

Disorders of acoustic nerve

0.00

0.20

0.0

1.4

—

6.09

—

Haemolytic anaemias

0.00

0.20

0.0

1.4

—

5.93

—

Systemic lupus erythematosus

0.00

0.20

0.0

1.3

—

5.99

—

Multiple myeloma, including Hilmo

0.00

0.20

0.0

1.1

—

6.34

—

Malignant neoplasm of eye, brain and central nervous system

0.00

0.20

0.0

1.4

—

5.97

—

Kidney transplant status

0.00

0.20

0.0

1.4

—

6.11

—

Tuberculosis

0.00

0.20

0.0

1.3

—

6.04

—

Exclusions for E4_PCOS_CONSORTIUM

352

0.92

0.20

1.2

1.4

5.93

5.57

mmol/l

2.01

352

Paroxysmal tachycardia

0.79

0.20

1.2

5.62

5.71

mmol/l

—

Seronegative rheumatoid arthritis

1.22

0.20

1.2

1.1

7.52

6.11

mmol/l

—

Carcinoma in situ of cervix uteri

112

0.80

0.20

2.0

1.3

5.46

5.41

mmol/l

—

112

Atopic dermatitis

374

1.09

0.20

1.3

1.4

5.34

5.72

mmol/l

3.10

374

Polycystic ovarian syndrome, consortium definition

352

1.08

0.20

1.3

1.4

5.75

5.53

mmol/l

1.08

352

Heterophoria

1.20

0.19

1.3

5.38

5.54

mmol/l

—

Myocardial infarction, unclassifiable

1.19

0.19

1.0

1.2

6.63

6.33

mmol/l

—

Hyperplasia of prostate

1.19

0.19

1.1

6.34

6.61

mmol/l

0.65

Cardiac murmurs and other cardiac sounds

1.16

0.19

1.3

1.4

5.30

5.48

mmol/l

—

Dermatitis

376

1.09

0.19

1.4

1.3

5.87

5.89

mmol/l

0.06

376

Substance abuse

319

0.90

0.19

1.2

6.17

5.94

mmol/l

1.04

319

288

0.90

0.19

1.2

6.26

5.97

mmol/l

0.99

288

Cerebrovascular diseases

224

0.90

0.19

1.1

6.48

6.23

mmol/l

0.31

224

Alzheimer’s disease (Late onset)

1.15

0.19

1.2

1.1

6.25

6.17

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

238

1.12

0.19

1.4

5.63

5.48

mmol/l

0.39

238

Type 2 diabetes, wide definition

230

0.90

0.19

1.1

1.2

6.85

5.89

mmol/l

2.35

230

Redundant prepuce, phimosis and paraphimosis

1.14

0.18

1.0

1.1

6.77

6.55

mmol/l

—

Other abnormal uterine and vaginal bleeding

1.17

0.18

1.2

1.3

5.77

5.62

mmol/l

0.38

Oral corticosteroids

450

0.94

0.18

1.3

6.28

5.73

mmol/l

2.10

450

Supplementary factors related to causes of morbidity and mortality classified elsewhere

175

0.86

0.18

1.4

1.2

5.53

5.87

mmol/l

0.87

175

Infections of the skin and subcutaneous tissue

378

0.91

0.18

1.3

5.80

5.83

mmol/l

0.06

378

Other and unspecified tonsillitis

248

1.11

0.18

1.4

5.66

5.47

mmol/l

0.63

248

Intracranial trauma

274

0.91

0.18

1.5

1.4

5.71

5.68

mmol/l

0.08

274

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

194

1.13

0.18

1.3

1.2

5.93

5.83

mmol/l

0.15

194

Psoriasis

132

0.83

0.18

1.5

1.2

6.03

5.97

mmol/l

0.07

132

Aneurysms, operations, SAH

1.21

0.18

1.1

7.76

6.16

mmol/l

—

Myocardial infarction

122

1.15

0.18

1.2

1.1

6.40

6.44

mmol/l

0.06

122

Pain and other conditions associated with female genital organs and menstrual cycle

178

1.13

0.18

1.3

1.5

5.55

5.34

mmol/l

0.47

178

Excessive attrition of teeth

441

0.92

0.18

1.3

6.01

5.70

mmol/l

1.28

441

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

198

0.88

0.18

1.4

1.5

5.74

5.26

mmol/l

1.17

198

Hypothyroidism, drug reimbursement

1.19

0.18

1.4

1.2

5.67

5.39

mmol/l

0.41

Later onset COPD, excluding more controls

1.16

0.18

1.0

1.1

6.20

6.40

mmol/l

—

Inflammatory disorders of breast

1.17

0.17

2.3

1.3

5.04

5.48

mmol/l

—

Restless leg syndrome

1.17

0.17

1.1

1.3

5.80

5.92

mmol/l

—

Unspecific neurodegenerative disorder

1.18

0.17

1.1

6.20

6.25

mmol/l

0.16

Sequelae of injuries, of poisoning and of other consequences of external causes

119

1.18

0.17

1.1

1.2

7.29

5.90

mmol/l

1.15

119

Dementia, including avohilmo

100

1.16

0.17

1.1

1.2

6.22

6.30

mmol/l

0.28

100

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

499

0.94

0.17

1.3

5.79

mmol/l

0.02

499

Angina pectoris

135

1.13

0.17

1.0

1.1

6.34

6.42

mmol/l

0.19

135

Disorders of thyroid, IBD co-morbidities

1.16

0.17

1.4

1.5

5.52

5.39

mmol/l

0.25

Other arrhythmias

310

1.08

0.17

1.2

5.98

5.95

mmol/l

0.08

310

Peritonsillar abscess

157

1.15

0.17

1.2

1.3

5.22

5.59

mmol/l

1.49

157

Other benign neoplasms of skin

176

1.14

0.17

1.3

1.2

6.14

5.96

mmol/l

0.46

176

COPD

124

0.85

0.17

1.1

6.18

6.24

mmol/l

0.16

124

Schizophrenia

1.13

0.17

1.7

1.2

6.39

5.92

mmol/l

—

External causes of morbidity and mortality

261

1.08

0.17

1.3

5.72

5.70

mmol/l

0.05

261

Congenital malformations of heart and great arteries

1.11

0.17

1.6

1.2

5.37

5.69

mmol/l

—

Cardiac arrhythmias

260

1.08

0.17

1.2

1.3

5.97

5.51

mmol/l

2.50

260

Disorders of breast

318

0.91

0.17

1.4

5.79

5.64

mmol/l

0.36

318

Tramadol

302

1.07

0.17

1.1

1.3

6.44

5.81

mmol/l

2.32

302

Panic disorder

129

1.16

0.17

1.5

1.3

5.79

5.46

mmol/l

0.74

129

Excessive earwax

299

0.91

0.17

1.1

1.2

5.99

6.06

mmol/l

0.19

299

Superficial injury of thorax

0.72

0.16

1.2

6.36

5.93

mmol/l

—

Other viral diseases, including avohilmo

279

1.10

0.16

1.5

1.3

5.77

5.63

mmol/l

0.43

279

Social phobias

0.71

0.16

1.2

5.76

5.50

mmol/l

—

Bacterial intestinal infections, IBD co-morbidities

1.13

0.16

1.0

1.2

6.23

5.93

mmol/l

—

Complications of surgical and medical care, not elsewhere classified

440

1.06

0.16

1.2

1.3

5.87

5.85

mmol/l

0.08

440

Ulcerative colitis, NAS

1.11

0.16

1.5

1.2

5.44

5.71

mmol/l

—

Coronary artery bypass grafting

0.78

0.16

1.0

1.2

6.30

6.35

mmol/l

—

Hypertensive heart and/or renal disease

0.76

0.16

1.0

1.1

6.38

6.15

mmol/l

—

Cardiodefibrillation

120

1.16

0.15

1.0

1.1

6.44

6.36

mmol/l

0.19

120

Finngen Rheumatological endpoints

409

0.94

0.15

1.3

1.4

6.13

5.69

mmol/l

1.60

409

Other (seronegative) rheumatoid arthritis, wide

1.10

0.15

1.1

1.2

7.20

6.06

mmol/l

—

Sulfasalazine

151

0.86

0.15

1.4

1.2

6.52

5.82

mmol/l

0.37

151

Complications predominantly related to the puerperium

235

1.11

0.15

1.6

1.4

5.27

5.51

mmol/l

1.08

235

Bitten or struck by other mammals

0.77

0.15

1.3

1.2

5.88

5.64

mmol/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.76

0.15

1.3

1.2

5.73

5.69

mmol/l

—

Other disorders of eye and adnexa

0.76

0.15

1.3

1.2

5.47

5.74

mmol/l

—

Diseases of the digestive system

212

0.89

0.15

1.3

1.2

5.92

6.03

mmol/l

0.22

212

Fracture of rib(s), sternum and thoracic spine

119

0.84

0.15

1.1

5.65

6.24

mmol/l

—

119

Calcific aortic valvular stenosis

1.12

0.15

1.0

1.1

6.17

6.34

mmol/l

—

Calcific aortic valvular stenosis, operated

1.12

0.15

1.0

1.1

6.17

6.34

mmol/l

—

Operations 2 for CAVS

1.12

0.15

1.0

1.1

6.17

6.34

mmol/l

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.12

0.15

1.0

1.1

6.17

6.34

mmol/l

—

Calcific aortic valvular stenosis, including rheumatic fever

1.12

0.15

1.0

1.1

6.17

6.34

mmol/l

—

Primary coxarthrosis, bilateral

102

1.18

0.15

1.2

1.1

6.27

mmol/l

0.00

102

Missing teeth due to accident, extraction or parodontitis

274

0.91

0.15

1.1

1.2

6.30

6.15

mmol/l

0.39

274

Fissure and fistula of anal and rectal regions

121

1.16

0.15

1.1

1.2

6.29

5.85

mmol/l

0.47

121

Gastroduodenal ulcer

1.11

0.15

1.3

1.1

6.28

6.24

mmol/l

—

Acute bronchitis

209

0.89

0.15

1.5

1.2

5.86

5.84

mmol/l

0.04

209

Injuries to the head

481

0.95

0.15

1.5

1.3

5.86

5.78

mmol/l

0.32

481

Injuries to the ankle and foot

464

0.94

0.14

1.5

1.3

5.46

5.77

mmol/l

1.46

464

Persons encountering health services for other counselling and medical advice, not elsewhere classified

409

0.95

0.14

1.3

5.83

5.82

mmol/l

0.02

409

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1.18

0.14

1.2

1.1

6.69

6.31

mmol/l

0.36

Systemic connective tissue disorders

171

0.88

0.14

1.1

1.2

5.86

5.88

mmol/l

0.02

171

Other predominantly sexually transmitted diseases, not elsewhere classified

150

0.87

0.14

1.4

1.3

5.20

5.51

mmol/l

1.01

150

Artrosis, including avohilmo

261

1.07

0.14

1.2

6.02

5.90

mmol/l

0.41

261

Liquid cancers

112

0.84

0.14

1.1

5.83

6.20

mmol/l

—

112

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.80

0.14

1.1

1.3

5.59

5.41

mmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.79

0.14

1.1

1.2

5.86

5.83

mmol/l

—

Primary open-angle glaucoma, strict

0.79

0.14

1.0

1.1

6.21

6.31

mmol/l

—

Post-traumatic stress disorder

1.18

0.14

1.2

1.3

6.25

5.41

mmol/l

1.34

Mycoses, including avohilmo

499

0.95

0.14

1.2

1.3

5.80

mmol/l

0.01

499

Endometriosis of pelvic peritoneum

117

0.85

0.14

1.4

5.37

5.50

mmol/l

0.23

117

Diseases of external ear

181

0.88

0.14

1.2

5.74

5.91

mmol/l

0.25

181

Benign neoplasms

414

1.05

0.14

1.3

1.4

5.90

5.70

mmol/l

1.15

414

Major coronary heart disease event excluding revascularizations

143

1.11

0.14

1.1

6.18

6.43

mmol/l

0.65

143

Any gastric operation

329

0.94

0.13

1.2

1.4

5.80

5.66

mmol/l

0.67

329

GASTRO-related operations

329

0.94

0.13

1.2

1.4

5.80

5.66

mmol/l

0.67

329

Other disorders of patella

103

1.17

0.13

1.2

5.95

5.79

mmol/l

0.15

103

Ventral hernia

103

1.17

0.13

1.1

6.41

6.14

mmol/l

0.67

103

Striking against or struck by other objects

201

0.89

0.13

1.4

1.3

5.51

5.82

mmol/l

0.75

201

Tumor necrosis factor alpha inhibitors

0.81

0.13

1.3

1.2

6.78

5.67

mmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

0.81

0.13

1.8

1.1

5.99

6.02

mmol/l

—

Coagulation defects, purpura and other haemorrhagic conditions

100

0.80

0.13

1.1

1.2

6.14

5.75

mmol/l

—

100

Pedal cyclist injured in transport accident

128

0.86

0.13

1.4

1.2

5.39

5.82

mmol/l

0.83

128

Disorders of vitreous body and globe

206

1.10

0.13

1.0

1.2

6.36

6.22

mmol/l

0.30

206

D07AA Corticosteroids, weak (group I)

103

1.16

0.13

1.4

1.3

5.43

5.56

mmol/l

0.32

103

Disorders of vestibular function (Vertigo)

216

0.90

0.13

1.3

1.2

6.22

6.02

mmol/l

0.57

216

Diseases of the skin and subcutaneous tissue

353

1.05

0.13

1.3

5.83

5.79

mmol/l

0.12

353

Other symptoms and signs involving cognitive functions and awareness

178

0.90

0.13

1.2

6.12

6.14

mmol/l

0.03

178

Anaemias

129

0.89

0.13

1.3

1.4

5.51

5.28

mmol/l

0.82

129

Cutaneous abscess, furuncle and carbuncle

159

0.88

0.13

1.2

5.79

5.88

mmol/l

0.12

159

Cervicobrachial syndrome

113

1.15

0.13

1.3

1.2

6.05

5.90

mmol/l

0.34

113

Unstable angina pectoris

1.15

0.13

1.0

1.1

6.13

6.39

mmol/l

0.58

Other sexually transmitted chlamydial diseases, including avohilmo

107

0.84

0.13

1.7

1.4

5.18

5.35

mmol/l

—

107

Biological medication for rheuma

109

0.83

0.13

1.4

1.2

6.77

5.67

mmol/l

—

109

Diseases of inner ear

246

1.09

0.13

1.2

6.14

6.06

mmol/l

0.20

246

Retention of urine

1.14

0.12

1.1

6.33

6.06

mmol/l

0.57

Other and unspecified iron deficiency

180

1.11

0.12

1.3

1.2

5.72

5.88

mmol/l

0.43

180

Injury, poisoning and certain other consequences of external causes

226

1.06

0.12

1.4

1.3

5.72

5.66

mmol/l

0.14

226

Mycoses

148

0.88

0.12

1.1

1.2

5.90

5.87

mmol/l

0.04

148

Behavioural syndromes associated with physiological disturbances and physical factors

451

1.05

0.12

1.4

1.3

5.71

5.79

mmol/l

0.33

451

Persistent mood disorders

104

1.15

0.12

1.5

1.2

6.10

5.74

mmol/l

0.65

104

Acute and subacute iridocyclitis

1.18

0.12

1.0

1.1

5.77

5.88

mmol/l

—

Personality disorders

200

1.10

0.12

1.5

1.3

6.20

5.55

mmol/l

2.68

200

Phobic anxiety disorders

116

0.86

0.12

1.1

1.3

5.83

5.44

mmol/l

—

116

Anomalies of dental arch relationship, including avohilmo

120

1.13

0.12

1.3

5.60

5.61

mmol/l

0.01

120

Heart failure and bmi 25plus

101

1.12

0.12

1.1

6.35

6.48

mmol/l

0.27

101

Embedded and impacted teeth

233

1.08

0.12

1.2

1.5

5.49

5.29

mmol/l

0.60

233

299

0.93

0.12

1.2

6.27

5.95

mmol/l

1.29

299

Appendicitis, broad definition

459

1.05

0.12

1.4

1.3

5.79

5.83

mmol/l

0.12

459

Convulsions, not elsewhere classified

135

0.88

0.11

1.2

1.3

5.69

5.81

mmol/l

0.13

135

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1.17

0.11

1.4

1.2

5.45

5.71

mmol/l

—

Injuries to the shoulder and upper arm

395

1.05

0.11

1.2

5.95

mmol/l

0.01

395

Suppurative and unspecified otitis media

258

0.93

0.11

1.5

1.4

5.65

5.42

mmol/l

0.64

258

Zoster [herpes zoster], including avohilmo

261

0.92

0.11

1.2

6.05

6.00

mmol/l

0.10

261

Glaucoma

186

0.91

0.11

1.3

1.1

6.03

6.25

mmol/l

0.78

186

Polyuria

1.16

0.11

1.6

1.2

6.32

6.08

mmol/l

—

Benzodiazepine use

486

0.96

0.11

1.2

1.3

6.03

5.76

mmol/l

1.73

486

Other extrapyramidal and movement disorders in other diseases

115

0.87

0.10

1.1

1.2

5.77

6.04

mmol/l

—

115

Nonsuppurative otitis media

175

1.09

0.10

1.6

1.5

5.45

5.34

mmol/l

0.30

175

Periodontitis

413

0.96

0.10

1.1

1.3

6.00

5.90

mmol/l

0.36

413

Other disorders of lacrimal gland

208

0.91

0.10

1.2

6.06

5.91

mmol/l

0.33

208

Hyperkinetic disorders

132

0.89

0.10

1.4

5.39

5.35

mmol/l

0.04

132

Diseases of appendix

460

1.05

0.10

1.4

1.3

5.79

5.83

mmol/l

0.13

460

Genitourinary diseases

189

1.06

0.10

1.2

1.3

5.77

5.71

mmol/l

0.14

189

N06DA Anticholinesterases

1.15

0.10

1.1

6.19

6.27

mmol/l

0.22

Use of anticholinesterases

1.15

0.10

1.1

6.19

6.27

mmol/l

0.22

Other chronic obstructive pulmonary disease

119

0.89

0.09

1.1

6.18

6.23

mmol/l

0.14

119

Cervicocranial syndrome

1.09

0.09

1.2

5.66

5.87

mmol/l

—

Viral infections characterized by skin and mucous membrane lesions

248

0.93

0.09

1.1

1.2

6.03

5.89

mmol/l

0.30

248

Peripheral artery disease

123

0.90

0.09

1.3

1.1

6.59

6.26

mmol/l

0.83

123

Other and unspecified dermatitis

320

1.06

0.09

1.4

1.3

5.84

5.91

mmol/l

0.16

320

Enthesopathies of lower limb, excluding foot

114

0.88

0.09

1.1

1.2

5.70

5.91

mmol/l

—

114

Mixed and other personality disorders

1.06

0.09

1.4

1.2

6.62

5.76

mmol/l

—

Open bite

1.04

0.09

1.8

1.3

5.80

5.45

mmol/l

—

Disorders of adult personality and behaviour

217

0.92

0.09

1.5

1.4

6.17

5.54

mmol/l

2.24

217

Alcohol use disorder, ICD-based

217

0.92

0.09

1.2

6.28

6.07

mmol/l

0.68

217

Erysipelas, including avohilmo

295

1.05

0.09

1.2

6.34

6.09

mmol/l

0.80

295

Other viral diseases, not elsewhere classified, including avohilmo

173

1.09

0.09

1.2

1.3

5.99

5.66

mmol/l

0.97

173

Tooth eruption problems

140

1.10

0.09

1.6

1.4

5.67

5.38

mmol/l

0.56

140

Complications of procedures, not elsewhere classified

424

1.04

0.09

1.2

1.3

5.81

5.86

mmol/l

0.18

424

All dysplastic lesions of the cervix uteri

258

1.07

0.09

1.6

1.4

5.32

5.45

mmol/l

0.44

258

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

439

0.95

0.09

1.2

1.4

5.61

5.71

mmol/l

0.31

439

HSIL lesion of the cervix uteri

196

0.92

0.09

1.7

1.4

5.28

5.48

mmol/l

0.58

196

Heartburn

1.11

0.09

1.7

1.2

6.02

5.86

mmol/l

—

Gastric ulcer

1.11

0.09

1.2

1.1

6.33

6.20

mmol/l

—

Abnormal findings on diagnostic imaging of other body structures

1.09

0.08

1.0

1.2

6.22

6.10

mmol/l

—

Pedal cyclist injured in noncollision transport accidents

1.07

0.08

1.3

5.60

5.74

mmol/l

—

Injury of muscle and tendon at wrist and hand level

1.05

0.08

1.3

1.2

5.88

5.93

mmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

1.05

0.08

1.3

1.2

5.88

6.05

mmol/l

—

Other CVD

1.05

0.08

1.0

1.1

6.10

6.22

mmol/l

—

Conjunctivitis (acute, non atopic), including avohilmo

425

1.04

0.08

1.2

1.3

5.82

5.85

mmol/l

0.08

425

Pollen allergy

142

0.90

0.08

1.4

5.57

5.49

mmol/l

0.13

142

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

151

1.06

0.08

1.2

1.4

5.80

5.57

mmol/l

0.65

151

Coxibs

1.11

0.08

1.1

1.4

5.89

5.55

mmol/l

0.88

Periapical abscess

263

1.06

0.08

1.1

1.2

6.22

6.00

mmol/l

0.71

263

Unspecified acute lower respiratory infection

0.83

0.08

1.2

1.3

5.60

5.98

mmol/l

—

Other inflammation of eyelid

0.81

0.08

1.0

1.2

6.58

5.91

mmol/l

—

Impacted maxillary molar

0.79

0.08

1.2

1.4

5.06

5.30

mmol/l

—

Irritable bowel syndrome

185

1.08

0.08

1.2

1.3

5.76

5.72

mmol/l

0.08

185

Hypo-osmolality and hyponatraemia

1.10

0.08

1.1

1.2

6.21

6.26

mmol/l

—

Persons encountering health services in other circumstances, wide

409

0.97

0.08

1.3

5.97

5.82

mmol/l

0.75

409

Dementia

1.10

0.08

1.1

6.21

6.28

mmol/l

0.25

ILD medications

449

1.03

0.08

1.2

1.3

6.02

5.72

mmol/l

1.09

449

Cardiovascular diseases (excluding rheumatic etc)

310

0.96

0.08

1.5

1.4

5.88

5.48

mmol/l

2.08

310

COPD (mode)

0.89

0.08

1.1

6.17

6.21

mmol/l

—

Chronic periodontitis, complicated

276

1.06

0.07

1.1

1.2

6.31

6.17

mmol/l

0.43

276

Hypertensive Heart Disease

0.81

0.07

1.0

1.1

6.38

6.16

mmol/l

—

Infections with a predominantly sexual mode of transmission, including avohilmo

318

0.95

0.07

1.5

1.4

5.35

5.46

mmol/l

0.47

318

Congenital malformations of the circulatory system

0.86

0.07

1.7

1.2

5.50

5.73

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.84

0.07

1.2

1.3

5.52

mmol/l

—

Thyroiditis, ILD-related definition

0.83

0.07

1.7

1.3

5.65

5.59

mmol/l

—

Aortic aneurysm

0.83

0.07

1.3

1.1

6.48

6.29

mmol/l

—

Care involving use of rehabilitation procedures

343

1.05

0.07

1.3

1.2

6.22

5.95

mmol/l

0.45

343

Early onset COPD, excluding more controls

0.81

0.07

1.2

1.1

6.15

mmol/l

—

Epilepsy

153

0.91

0.07

1.1

1.2

6.14

5.97

mmol/l

0.27

153

Other bacterial intestinal infections

1.08

0.07

1.0

1.2

6.23

6.00

mmol/l

—

Superficial injury of ankle and foot

1.07

0.07

1.3

5.68

5.66

mmol/l

—

Salpingitis and oophoritis

1.05

0.07

1.3

1.2

5.90

5.96

mmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1.05

0.07

1.1

6.16

6.32

mmol/l

—

Polyneuropathies and other disorders of the peripheral nervous system

1.04

0.07

1.5

1.1

6.28

6.17

mmol/l

—

Other disorders of bone

108

1.11

0.07

1.5

1.2

5.38

5.79

mmol/l

1.07

108

Other symptoms and signs involving the digestive system and abdomen

1.03

0.07

1.4

1.2

5.06

5.90

mmol/l

—

Emotionally unstable personality disorder

112

0.89

0.07

1.2

1.3

6.02

5.49

mmol/l

—

112

Injury of eye and orbit

0.87

0.07

1.0

1.2

5.84

5.73

mmol/l

—

Disorders of lipoprotein metabolism and other lipidaemias

256

1.04

0.07

1.1

1.2

6.59

6.11

mmol/l

1.25

256

Follicular cysts of skin and subcutaneous tissue

1.07

0.07

1.0

1.2

6.26

5.93

mmol/l

—

Psoriasis vulgaris

1.06

0.07

1.4

1.2

6.22

6.00

mmol/l

—

Other skin changes

1.06

0.07

1.1

1.2

5.94

6.00

mmol/l

—

Enlarged lymph nodes

1.06

0.07

1.1

1.2

5.58

5.97

mmol/l

—

Other diseases of urinary system

397

1.03

0.07

1.2

1.4

6.08

5.72

mmol/l

2.22

397

Type of accident

163

0.92

0.07

1.4

1.2

5.53

5.85

mmol/l

0.82

163

Other degenerative diseases of the nervous system

1.10

0.07

1.2

5.89

6.05

mmol/l

0.29

General symptoms and signs

399

1.03

0.07

1.2

1.4

5.80

5.76

mmol/l

0.10

399

Osteoporosis

0.87

0.06

1.3

1.1

5.96

6.13

mmol/l

—

Focal epilepsy, strict definition

0.88

0.06

1.1

1.2

5.89

5.85

mmol/l

—

Leisure time condition

0.86

0.06

1.5

1.2

5.41

5.78

mmol/l

—

Seborrhoeic keratosis

0.85

0.06

1.0

1.1

6.10

6.19

mmol/l

—

Exclusions for E4_PCOS_BROAD

1.12

0.06

1.0

1.2

7.52

5.69

mmol/l

—

Organic, including symptomatic, mental disorders

131

1.07

0.06

1.1

6.22

mmol/l

0.02

131

Any dementia, excluding more controls

0.90

0.06

1.1

6.31

6.30

mmol/l

—

Extrapyramidal and movement disorders

183

0.93

0.06

1.3

1.2

6.07

6.05

mmol/l

0.04

183

Thyrotoxicosis

138

1.09

0.06

1.3

1.2

5.75

5.82

mmol/l

0.09

138

Urolithiasis

138

1.09

0.06

1.4

1.1

5.93

6.15

mmol/l

0.48

138

Cervicalgia

100

0.90

0.06

1.2

5.88

5.86

mmol/l

—

100

Psychiatric diseases

351

0.97

0.06

1.3

5.85

5.81

mmol/l

0.13

351

Substance use, excluding alcohol

104

0.87

0.06

1.2

6.30

5.72

mmol/l

—

104

Primary open-angle glaucoma

101

0.86

0.06

1.0

1.1

6.07

6.31

mmol/l

—

101

Appendectomy

431

1.04

0.06

1.4

1.3

5.69

5.76

mmol/l

0.19

431

Other reaction to severe stress, and adjustment disorders

284

0.95

0.06

1.5

1.4

5.59

5.55

mmol/l

0.08

284

Abnormal findings on examination of blood, without diagnosis

196

1.06

0.06

1.2

6.10

6.11

mmol/l

0.00

196

ILD medications: prednisolone, methylprednisolone, prednisone

445

0.97

0.06

1.2

1.3

6.17

5.72

mmol/l

1.66

445

Fracture at wrist and hand level

192

0.93

0.06

1.4

1.2

5.81

5.90

mmol/l

0.10

192

Ovarian cyst

186

0.95

0.06

1.3

1.5

5.69

5.40

mmol/l

1.18

186

Other viral diseases

187

1.07

0.05

1.4

1.3

5.71

5.67

mmol/l

0.06

187

Erysipelas

238

1.05

0.05

1.1

1.2

6.33

6.13

mmol/l

0.41

238

Hallux valgus (acquired)

106

1.08

0.05

1.2

6.07

6.11

mmol/l

0.08

106

Unspecified mental disorder

253

0.95

0.05

1.3

6.37

5.75

mmol/l

3.65

253

Dental caries

1.10

0.05

1.2

1.3

6.31

5.79

mmol/l

0.51

Cardiovascular diseases

288

1.03

0.05

1.5

1.4

5.69

5.42

mmol/l

1.26

288

Migraine without aura and triptan purchases

151

0.93

0.05

1.2

1.4

5.17

5.58

mmol/l

0.93

151

Abrasion of teeth

212

0.94

0.05

1.3

1.2

6.07

5.89

mmol/l

0.32

212

Alzheimer disease, including avohilmo

1.10

0.05

1.1

6.20

6.19

mmol/l

0.02

Hypothyroidism, strict autoimmune, 3 medication purchases required

405

1.03

0.05

1.3

1.4

5.82

5.69

mmol/l

0.59

405

Disturbance of activity and attention

127

0.92

0.04

1.4

5.39

5.30

mmol/l

0.10

127

Ischaemic Stroke, excluding all haemorrhages

146

1.06

0.04

1.1

6.54

6.26

mmol/l

0.24

146

Papulosquamous disorders

191

0.94

0.04

1.3

1.2

5.96

6.01

mmol/l

0.08

191

malignant neoplasm of male genital organs, including Hilmo

0.91

0.04

1.5

1.1

6.41

6.62

mmol/l

—

Colonic or urogenital fistula

140

1.07

0.04

1.1

1.2

6.33

5.90

mmol/l

0.49

140

Any mental disorder

387

1.02

0.04

1.3

5.95

5.79

mmol/l

1.02

387

Liquid cancers, including Hilmo

132

1.07

0.04

1.3

1.1

6.03

6.25

mmol/l

0.47

132

Symptoms and signs involving the urinary system

307

1.03

0.04

1.3

1.2

6.18

6.00

mmol/l

0.73

307

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

109

0.92

0.04

1.4

1.2

5.74

5.62

mmol/l

—

109

Other disorders of urethra and urinary system

343

0.97

0.04

1.3

1.4

5.88

5.64

mmol/l

0.99

343

Disorders of lens

191

1.04

0.04

1.0

1.2

6.22

6.36

mmol/l

0.48

191

LSIL lesion of the cervix uteri

111

1.08

0.04

1.2

1.3

5.34

5.51

mmol/l

0.42

111

Intracranial injury

337

0.97

0.04

1.4

1.3

5.67

5.81

mmol/l

0.45

337

Postpartum haemorrhage due to anatomy

190

1.05

0.04

1.3

1.5

5.12

5.22

mmol/l

0.40

190

Other diseases of upper respiratory tract

388

0.98

0.04

1.2

1.3

6.05

5.80

mmol/l

0.81

388

Bipolar affective disorders

131

1.07

0.03

1.0

1.3

6.44

5.55

mmol/l

4.57

131

Viral warts, including avohilmo

139

0.94

0.03

1.4

1.3

5.65

mmol/l

0.01

139

Postpartum haemorrhage due to retained placenta

179

0.95

0.03

1.5

5.15

5.40

mmol/l

0.85

179

Anterior Iridocyclitis

1.09

0.03

1.0

1.2

5.77

5.90

mmol/l

—

Diseases of the eye and adnexa

332

0.98

0.03

1.3

1.4

5.85

5.63

mmol/l

1.03

332

Malignant neoplasm of prostate, including Hilmo

0.92

0.03

1.5

1.1

6.41

6.63

mmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

156

0.95

0.03

1.0

1.1

7.04

6.09

mmol/l

2.51

156

Anti-inflammatory and antirheumatic products, non-steroids

1.06

0.02

1.4

5.77

5.55

mmol/l

0.53

Ectopic pregnancy

122

1.07

0.02

1.6

1.3

5.87

5.67

mmol/l

0.40

122

Calculus of kidney and ureter

122

1.07

0.02

1.5

1.2

5.91

6.15

mmol/l

0.46

122

Malignant neoplasm of prostate

0.92

0.02

1.5

1.1

6.41

6.63

mmol/l

—

Metabolic disorders

341

1.02

0.02

1.1

1.2

6.31

5.92

mmol/l

1.23

341

Other anxiety disorders

323

0.97

0.02

1.2

1.4

5.68

5.52

mmol/l

0.51

323

Endometriosis

180

0.97

0.02

1.1

1.5

5.60

5.41

mmol/l

0.56

180

Other heart diseases

188

0.97

0.02

1.3

1.2

6.02

5.72

mmol/l

0.84

188

malignant neoplasm of male genital organs

0.93

0.02

1.5

1.1

6.41

6.62

mmol/l

—

Migraine without aura

168

0.95

0.02

1.2

1.4

5.18

5.42

mmol/l

0.53

168

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

449

0.98

0.02

1.4

1.3

5.75

5.81

mmol/l

0.30

449

Other external causes of accidental injury

311

0.98

0.02

1.3

5.79

5.77

mmol/l

0.06

311

Diagnoses used for exclusion with ILD

1.08

0.02

1.0

1.2

6.50

6.10

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

166

1.04

0.02

1.2

1.1

6.21

6.28

mmol/l

0.25

166

Personality disorders, excluding more controls

212

1.04

0.01

1.5

1.4

6.20

5.52

mmol/l

2.77

212

Arthropathies

359

1.01

0.01

1.3

1.4

5.64

5.65

mmol/l

0.04

359

Acetic acid derivatives and related substances

0.95

0.01

1.4

5.75

5.55

mmol/l

0.34

Medical treatment for female infertility

225

0.97

0.01

1.5

5.21

5.47

mmol/l

0.85

225

HSIL lesion of the cervix uteri, vagina or vulva

203

1.03

0.01

1.6

1.4

5.38

5.50

mmol/l

0.35

203

Caries of enamel

450

0.99

0.01

1.3

5.68

5.86

mmol/l

1.10

450

Artificial joint operation, meniscal resection

299

0.98

0.01

1.1

1.2

6.25

6.16

mmol/l

0.29

299

Other systemic involvement of connective tissue (FG)

131

1.05

0.01

1.1

1.2

5.89

5.85

mmol/l

0.05

131

Sequelae of cerebrovascular disease

108

0.95

0.01

1.0

1.1

6.23

6.22

mmol/l

0.02

108

Female genital prolapse

0.96

0.01

1.3

5.72

5.74

mmol/l

0.02

Symptoms and signs involving the digestive system and abdomen

352

1.01

0.00

1.3

5.78

mmol/l

0.01

352

Conduction disorders

0.95

0.00

1.1

1.2

6.06

6.12

mmol/l

0.07

Inflammatory bowel disease treatment related agents

464

0.99

0.00

1.2

1.3

6.19

5.72

mmol/l

1.99

464

Nausea and vomiting

142

0.96

0.00

1.4

1.3

6.42

5.75

mmol/l

0.98

142

Nonsuppurative otitis media, including avohilmo

237

1.02

0.00

1.5

1.4

5.48

5.40

mmol/l

0.20

237

Open wound of head

260

1.01

0.00

1.5

1.2

6.05

6.08

mmol/l

0.08

260

Other disorders of skin and subcutaneous tissue

347

1.00

0.00

1.2

6.02

5.96

mmol/l

0.14

347

Diseases of arteries, arterioles and capillaries

212

1.00

0.00

1.2

1.1

6.34

6.21

mmol/l

0.37

212

Alcohol use disorder, Swedish definition

266

0.99

0.00

1.2

6.33

6.01

mmol/l

1.17

266

Combinations of oral blood glucose lowering drugs

107

1.03

0.00

1.0

1.1

7.94

6.10

mmol/l

1.21

107

Injuries to the abdomen, lower back, lumbar spine and pelvis

215

1.01

0.00

1.6

1.2

5.74

5.83

mmol/l

0.17

215

Other and unspecified effects of external causes

188

1.01

0.00

1.4

1.2

5.98

5.63

mmol/l

0.88

188

Factors influencing health status and contact with health services

0.97

0.00

1.4

1.2

6.06

6.21

mmol/l

0.30

Other bacterial intestinal infections, including avohilmo

123

0.98

0.00

1.2

5.97

5.88

mmol/l

0.15

123

Inflammatory disease of uterus

137

1.02

0.00

1.6

1.3

5.88

5.55

mmol/l

0.55

137

Syncope and collapse

194

0.99

0.00

1.3

1.2

5.93

5.88

mmol/l

0.08

194

Disorders of sclera, cornea, iris and ciliary body

337

1.01

0.00

1.3

5.99

5.87

mmol/l

0.41

337

Disorders of refraction and accommodation

188

1.01

0.00

1.4

1.3

5.97

5.71

mmol/l

0.71

188

Dermatophytosis, including avohilmo

414

0.99

0.00

1.2

1.3

5.85

5.86

mmol/l

0.04

414

Dysplasia of cervi uteri

176

1.00

0.00

1.4

1.5

5.29

5.38

mmol/l

0.27

176

Abnormal findings in secretions and smears from cervix uteri vagina vulva

337

1.00

0.00

1.5

1.4

5.37

5.57

mmol/l

1.22

337

Other puerperal infections

102

0.98

0.00

1.5

1.4

4.98

5.38

mmol/l

—

102

Leiomyoma of uterus

213

1.00

0.00

1.2

1.3

6.10

5.81

mmol/l

1.14

213

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

381

1.00

0.00

1.5

1.4

5.45

5.66

mmol/l

1.18

381

Other heart diseases, wide

391

1.01

0.00

1.2

1.3

5.97

5.81

mmol/l

0.72

391

Iridocyclitis

115

1.04

0.00

1.0

1.1

5.88

5.85

mmol/l

0.07

115

Menorrhagia

159

0.98

0.00

1.4

5.79

5.46

mmol/l

1.02

159

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

185

0.97

0.00

1.4

5.27

5.42

mmol/l

0.49

185

Symptoms and signs involving the skin and subcutaneous tissue

439

0.99

0.00

1.3

5.81

5.82

mmol/l

0.02

439

Deviated nasal septum

155

0.97

0.00

1.2

1.1

6.43

6.07

mmol/l

0.21

155

Oxicams

1.05

0.00

1.3

1.4

5.98

5.67

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

291

0.98

0.00

1.6

1.4

5.46

5.58

mmol/l

0.26

291

Glaucoma suspect

139

1.01

0.00

1.4

1.1

5.88

6.18

mmol/l

1.07

139

Other specified/unspecified arthritis

144

0.97

0.00

1.1

1.2

6.89

5.93

mmol/l

0.64

144

Symptoms and signs involving speech and voice

164

0.98

0.00

1.1

1.2

5.87

5.96

mmol/l

0.15

164

Hernia of abdominal wall

234

0.98

0.00

1.2

6.15

6.06

mmol/l

0.19

234

Other complications of labour and delivery, not elsewhere classified

122

1.02

0.00

1.2

1.5

5.07

5.31

mmol/l

1.14

122

LSIL lesion of the cervix uteri, vagina or vulva

128

1.02

0.00

1.2

1.3

5.45

5.61

mmol/l

0.35

128

Superficial injury of wrist and hand

132

0.98

0.00

1.5

1.3

5.32

5.66

mmol/l

0.76

132

Noninfective enteritis and colitis

265

1.02

0.00

1.4

1.3

5.67

5.84

mmol/l

0.49

265

Fall on same level involving ice and snow

345

0.98

0.00

1.3

6.18

5.87

mmol/l

0.46

345

Fracture of foot, except ankle

158

1.01

0.00

1.3

1.2

5.37

5.79

mmol/l

1.44

158

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

305

1.01

0.00

1.3

6.40

5.92

mmol/l

0.74

305

Specific personality disorders

178

1.01

0.00

1.6

1.3

6.11

5.58

mmol/l

1.58

178

Voice disturbances

135

0.96

0.00

1.2

5.86

5.95

mmol/l

0.14

135

Alcohol dependence

105

0.95

0.00

1.0

1.2

6.23

6.21

mmol/l

—

105

Acute alcohol intoxication

117

1.03

0.00

1.1

1.2

5.93

5.96

mmol/l

0.05

117

All influenza

123

0.98

0.00

1.3

1.2

5.79

5.93

mmol/l

0.26

123

Other systemic involvement of connective tissue

141

0.99

0.00

1.1

1.2

5.89

5.86

mmol/l

0.04

141

Accidents

311

1.00

0.00

1.3

5.74

5.77

mmol/l

0.07

311

In situ neoplasms

227

1.01

0.00

1.4

1.2

5.87

5.85

mmol/l

0.04

227

Retinal detachments and breaks

132

0.98

0.00

1.3

1.1

6.22

6.17

mmol/l

0.08

132

Stroke, excluding SAH

150

1.01

0.00

1.1

6.54

6.25

mmol/l

0.25

150

Impacted teeth

193

1.02

0.00

1.1

1.5

5.40

5.29

mmol/l

0.27

193

Excessive, frequent and irregular menstruation

190

1.01

0.00

1.4

1.5

5.61

5.40

mmol/l

0.61

190

Superficial injury of head

119

1.01

0.00

1.6

1.2

5.81

5.85

mmol/l

0.07

119

Childhood allergy (age < 16)

136

1.03

0.00

1.6

1.5

5.07

5.18

mmol/l

0.36

136

Stroke, including SAH

165

1.00

0.00

1.1

6.46

6.23

mmol/l

0.20

165

Poisoning by drugs, medicaments and biological substances

155

0.97

0.00

1.1

1.3

6.01

5.66

mmol/l

1.10

155

Combined immunodeficiencies

0.00

0.0

1.4

—

6.26

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

0.92

0.00

1.5

1.4

5.65

5.42

mmol/l

—

Nontoxic multinodular goitre

0.87

0.00

1.3

1.2

5.82

6.03

mmol/l

—

Hypocalcemia

0.00

0.0

1.5

—

6.11

—

Malnutrition

0.00

0.0

1.6

—

6.18

—

Systemic sclerosis,strict definition

0.00

0.0

1.6

—

6.06

—

Benign neoplasm: Scapula and long bones of upper limb

0.00

0.0

1.4

—

6.20

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.00

0.0

1.6

—

5.88

—

Hypertensive Renal Disease

0.00

0.0

1.0

—

6.46

—

Other and unspecified hydrocephalus

0.00

0.0

1.7

—

5.97

—

Personal history of risk-factors, not elsewhere classified

0.00

0.0

1.6

—

5.81

—

Adhesive capsulitis of shoulder

0.98

0.00

1.2

1.1

5.98

6.15

mmol/l

—

Alcohol abuse counselling and surveillance

0.00

0.0

1.5

—

5.85

—

Assault by sharp object

0.00

0.0

1.5

—

5.99

—

Failure and rejection of transplanted organs and tissues

0.00

0.0

1.7

—

5.83

—

Systemic sclerosis, icd10

0.00

0.0

1.4

—

6.17

—

Superficial injury of neck

0.00

0.0

1.5

—

5.86

—

Disorders of oesophagus in diseases classified elsewhere

0.00

0.0

1.5

—

6.36

—

Abnormal involuntary movements

0.88

0.00

1.2

5.56

5.92

mmol/l

—

Macular cyst

0.00

0.0

1.0

—

6.21

—

Spinal enthesopathy

0.00

0.0

1.6

—

6.18

—

Spinal osteochondrosis

0.00

0.0

1.6

—

5.88

—

Panniculitis, unspecified

0.00

0.0

1.2

—

6.17

—

Morphin

0.00

0.0

1.1

—

6.29

—

Other and unspecified nonscarring hair loss

0.00

0.0

1.6

—

5.88

—

Other melanin hyperpigmentation

0.00

0.0

1.4

—

6.25

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.00

0.0

1.3

—

6.32

—

Other disorders of male genital organs

0.00

0.0

1.0

—

6.67

—

Adhesive middle ear disease

0.00

0.0

1.6

—

6.28

—

Encephalitis

0.00

0.0

1.6

—

6.17

—

Habit and impulse disorders

0.00

0.0

1.3

—

6.22

—

Endocrine disorders, other/unspecified

0.00

0.0

1.4

—

6.16

—

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

0.0

1.4

—

5.96

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.4

—

6.06

—

Benign neoplasm: Larynx

0.00

0.0

1.6

—

5.99

—

Alzheimer’s disease, strict definition

0.93

0.00

1.2

6.25

6.19

mmol/l

—

Whooping cough, including avohilmo

0.00

0.0

1.4

—

5.71

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

0.00

0.0

1.2

—

6.25

—

Zoster [herpes zoster]

0.88

0.00

1.0

1.2

6.55

6.00

mmol/l

—

Benign neoplasm: Short bones of upper limb

0.00

0.0

1.4

—

6.12

—

Trichomoniasis

0.00

0.0

1.6

—

5.86

—

Use of donepezil

1.01

0.00

1.0

1.1

6.36

6.21

mmol/l

—

Chronic mastoiditis

0.00

0.0

1.6

—

6.40

—

Urethritis and urethral syndrome

0.00

0.0

1.2

—

6.21

—

Abscess of external ear

0.00

0.0

1.7

—

5.83

—

Other protozoal intestinal diseases

0.00

0.0

1.5

—

6.12

—

Acute poliomyelitis, including avohilmo

0.00

0.0

1.6

—

6.40

—

Post-traumatic wound infection, not elsewhere classified

0.00

0.0

1.5

—

6.00

—

Open wound of thorax

0.00

-0.00

0.0

1.6

—

5.88

—

Deep endometriosis

1.00

-0.00

1.0

1.3

6.00

5.58

mmol/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

0.00

-0.00

0.0

1.2

—

6.20

—

Traumatic subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

6.27

—

Burn and corrosion confined to eye and adnexa

0.00

-0.00

0.0

1.5

—

6.01

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

-0.00

0.0

1.4

—

5.64

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

140

1.00

-0.00

1.1

1.2

7.01

5.99

mmol/l

2.08

140

Blood alcohol or alcohol intoxication level

0.00

-0.00

0.0

1.7

—

5.83

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

-0.00

0.0

1.7

—

5.83

—

Injury of muscle and tendon at forearm level

0.00

-0.00

0.0

1.4

—

5.98

—

Open wound of shoulder and upper arm

0.00

-0.00

0.0

1.6

—

5.87

—

Viral pneumonia

0.93

-0.00

1.2

5.34

5.95

mmol/l

—

Burns and corrosions of external body surface, specified by site

1.02

-0.00

1.6

1.3

5.50

5.74

mmol/l

—

Adenomyosis (Endometriosis of uterus)

0.98

-0.00

1.0

1.3

5.79

5.63

mmol/l

—

Embolic stroke

0.00

-0.00

0.0

1.4

—

5.98

—

IgA nephropathy (IgA glomerulonephritis)

0.00

-0.00

0.0

1.6

—

5.94

—

Unspecified lump in breast

0.95

-0.00

1.6

1.3

5.99

5.88

mmol/l

—

Use of ropinirole

0.00

-0.00

0.0

1.3

—

6.37

—

Use of rasagiline

0.00

-0.00

0.0

1.3

—

6.23

—

Epiphora

0.00

-0.00

0.0

1.5

—

5.97

—

Accidental poisoning by and exposure to alcohol

0.00

-0.00

0.0

1.5

—

5.97

—

Hereditary retinal dystrophy

0.00

-0.00

0.0

1.3

—

6.13

—

Left hemicolectomy

0.00

-0.00

0.0

1.2

—

6.30

—

Use of amantadine

0.00

-0.00

0.0

1.4

—

6.34

—

Inflammation of lacrimal passages (acute and unspecified)

0.00

-0.00

0.0

1.4

—

6.10

—

Nystagmus and other irregular eye movements

0.00

-0.00

0.0

1.6

—

6.10

—

Intentional self-harm by unspecified means

0.00

-0.00

0.0

1.9

—

5.89

—

Embolic stroke with flimmer

0.00

-0.00

0.0

1.2

—

5.80

—

Certain conditions originating in the perinatal period

0.84

-0.00

1.0

1.4

5.96

5.36

mmol/l

—

Moderate visual impairment, binocular

0.00

-0.00

0.0

1.5

—

6.05

—

Laparoscopic left hemicolectomy

0.00

-0.00

0.0

1.3

—

6.57

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

-0.00

0.0

1.6

—

5.92

—

Exposure to other and unspecified man-made environmental factors

0.00

-0.00

0.0

1.4

—

6.03

—

Acute epiglottitis

0.00

-0.00

0.0

1.6

—

5.94

—

Sequelae of other accidents

0.00

-0.00

0.0

1.6

—

6.10

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.7

—

5.49

—

Outcome of delivery

0.99

-0.00

1.0

1.5

6.04

5.92

mmol/l

—

Malignant neoplasm of brain

0.00

-0.00

0.0

1.3

—

6.20

—

Trichomoniasis, including avohilmo

0.00

-0.00

0.0

1.6

—

5.86

—

Tibial collateral bursitis [Pellegrini-Stieda]

0.00

-0.00

0.0

1.6

—

5.90

—

Acute nephritic syndrome

0.00

-0.00

0.0

1.6

—

6.03

—

Other dialysis

0.00

-0.00

0.0

1.4

—

6.02

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

6.17

—

Personal history of other diseases and conditions

1.01

-0.00

1.3

5.16

5.51

mmol/l

—

Iliotibial band syndrome

0.00

-0.00

0.0

1.2

—

6.32

—

Alzheimer disease

0.94

-0.00

1.1

6.31

6.17

mmol/l

—

Early syphilis

0.00

-0.00

0.0

1.7

—

5.98

—

Shoulder region

0.00

-0.00

0.0

1.6

—

5.88

—

Contracture of joint

0.00

-0.00

0.0

1.4

—

6.60

—

Prurigo nodularis

0.00

-0.00

0.0

1.6

—

6.21

—

Infection of intervertebral disc (pyogenic)

0.00

-0.00

0.0

1.3

—

6.28

—

Calcaneal spur

0.00

-0.00

0.0

1.2

—

6.28

—

Previous suicide attempt

0.00

-0.00

0.0

1.7

—

5.83

—

Other nonscarring hair loss

0.00

-0.00

0.0

1.6

—

5.88

—

Acquired stenosis of external ear canal

0.00

-0.00

0.0

1.4

—

6.28

—

Isolated proteinuria with specified morphological lesion

0.00

-0.00

0.0

1.6

—

6.04

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.8

—

5.92

—

Other disorders of breast

0.99

-0.00

1.4

1.3

5.61

5.71

mmol/l

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.8

—

5.92

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

-0.00

0.0

1.6

—

5.55

—

Other crystal arthropathies

0.00

-0.00

0.0

1.3

—

6.23

—

Other bursitis of hip

0.00

-0.00

0.0

1.3

—

6.07

—

Other abnormal auditory perceptions

0.00

-0.00

0.0

1.6

—

5.86

—

Benign neoplasm: other/unspecified salivary gland

0.00

-0.00

0.0

1.2

—

6.46

—

Anorexia

0.00

-0.00

0.0

1.6

—

6.18

—

Other and unspecified vasculitis limited to skin

0.00

-0.00

0.0

1.5

—

6.22

—

Polymorphous light eruption

0.00

-0.00

0.0

1.6

—

5.92

—

Guttate psoriasis

0.00

-0.00

0.0

1.6

—

6.23

—

Other congenital malformations of peripheral vascular system

0.00

-0.00

0.0

1.6

—

6.10

—

Pemphigoid

0.00

-0.00

0.0

1.5

—

6.22

—

Lichen planus, including avohilmo

1.00

-0.00

1.1

6.19

6.09

mmol/l

—

Pneumocystosis

0.00

-0.00

0.0

1.7

—

5.97

—

Acidosis

0.00

-0.00

0.0

1.2

—

6.46

—

Purpura and other haemorrhagic conditions

0.88

-0.00

1.0

1.2

6.46

5.84

mmol/l

—

Colitis, primary sclerosing

0.00

-0.00

0.0

1.7

—

5.97

—

Carcinoma in situ of skin of lower limb, including hip

0.00

-0.00

0.0

1.6

—

6.26

—

Pneumocystosis, including avohilmo

0.00

-0.00

0.0

1.7

—

5.97

—

Other viral diseases, not elsewhere classified

0.97

-0.00

1.1

1.2

6.04

5.77

mmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.00

-0.00

1.2

1.1

6.36

6.12

mmol/l

—

Scissor bite

0.00

-0.00

0.0

1.5

—

6.13

—

Other diseases of appendix

0.00

-0.00

0.0

1.8

—

6.18

—

Dependent personality disorder

0.00

-0.00

0.0

1.2

—

6.36

—

Respiratory conditions due to other external agents

0.00

-0.00

0.0

1.6

—

5.96

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.4

—

5.97

—

Primary Sclerosing Cholangitis, IBD and UDCA required

0.00

-0.00

0.0

1.3

—

6.25

—

Rheumatic fever incl heart disease

0.00

-0.00

0.0

1.4

—

6.11

—

Personal history of allergy to drugs, medicaments and biological substances

0.00

-0.00

0.0

1.5

—

6.21

—

Other and unspecified mononeuropathies, also in other diseases

0.00

-0.00

0.0

1.1

—

5.97

—

Monoplegia

0.00

-0.00

0.0

1.6

—

6.08

—

Status epilepticus

0.00

-0.00

0.0

1.2

—

6.24

—

Other and unspecified polyneuropathies, also in other diseases

0.94

-0.00

1.7

1.2

6.22

6.17

mmol/l

—

Other arterial embolism and thrombosis

0.00

-0.00

0.0

1.4

—

6.24

—

Vasculitis limited to skin, not elsewhere classified

0.00

-0.00

0.0

1.5

—

6.26

—

Other bursitis of knee

0.00

-0.00

0.0

1.3

—

6.07

—

Intussusception

0.00

-0.00

0.0

1.1

—

6.51

—

Dronedarone medication

0.00

-0.00

0.0

1.1

—

6.40

—

Dermatitis herpetiformis

0.00

-0.00

0.0

1.7

—

5.97

—

Measles, including avohilmo

0.00

-0.00

0.0

1.6

—

5.77

—

Cleft lip, lip and palate or palate

0.00

-0.00

0.0

1.6

—

5.93

—

Helminthiases

0.00

-0.00

0.0

1.5

—

6.12

—

Hypersensitivity pneumonitis due to organic dust

0.00

-0.00

0.0

1.7

—

5.83

—

Other congenital malformations

0.88

-0.00

1.8

1.3

5.74

5.51

mmol/l

—

Other osteochondrodysplasias, including avohilmo

0.00

-0.00

0.0

1.8

—

5.92

—

Prominent ears

0.00

-0.00

0.0

1.4

—

5.36

—

Benign neoplasm of other and ill-defined parts of digestive system

1.01

-0.00

1.1

5.70

6.12

mmol/l

—

Rubella [German measles]

0.00

-0.00

0.0

1.1

—

6.40

—

Spondylopathies (FG)

0.90

-0.00

1.0

1.2

6.24

5.73

mmol/l

—

Other respiratory diseases principally affecting the interstitium

1.02

-0.00

1.4

1.1

6.34

6.26

mmol/l

—

Postmenopausal atrophic vaginitis

0.98

-0.00

1.2

5.83

6.13

mmol/l

—

Other intracranial haemorrhages

0.00

-0.00

0.0

1.2

—

6.23

—

Crowding of teeth, including avohilmo

0.97

-0.00

1.1

1.3

5.06

5.45

mmol/l

—

LSIL lesion of the vagina

0.00

-0.00

0.0

1.4

—

6.04

—

Certain zoonotic bacterial diseases

0.00

-0.00

0.0

1.8

—

5.92

—

Retinoschisis and retinal cysts

0.00

-0.00

0.0

1.3

—

6.10

—

Vascular dementia (subcortical)

0.00

-0.00

0.0

1.0

—

6.02

—

Inflammation of lacrimal passages (chronic)

0.00

-0.00

0.0

1.6

—

5.96

—

Cellulitis of external ear

0.00

-0.00

0.0

1.6

—

5.88

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.96

-0.00

1.1

1.3

5.59

5.54

mmol/l

—

Erythema multiforme

0.00

-0.00

0.0

1.4

—

6.12

—

Vitiligo

0.00

-0.00

0.0

1.6

—

6.07

—

Diplopia

0.96

-0.00

1.0

1.2

5.94

5.99

mmol/l

—

Other specified and unspecified disorders of eyelid

0.00

-0.00

0.0

1.6

—

5.66

—

Villonodular synovitis (pigmented)

0.00

-0.00

0.0

1.0

—

6.50

—

Glucagon-like peptide-1 (GLP-1) analogues

140

1.00

-0.00

1.1

1.2

7.01

5.99

mmol/l

2.08

140

Other disorders affecting eyelid function

0.00

-0.00

0.0

1.6

—

6.04

—

Disorders of optic nerve, not elsewhere classified

0.00

-0.00

0.0

1.2

—

6.30

—

Other lesions of median nerve

0.00

-0.00

0.0

1.0

—

6.00

—

Optic atrophy, wide definition

0.00

-0.00

0.0

1.2

—

5.94

—

Other conjunctival vascular disorders and cysts

0.00

-0.00

0.0

1.4

—

6.30

—

Generalized epilepsy, strict definition

0.00

-0.00

0.0

1.4

—

5.82

—

Small cell lung cancer

0.00

-0.00

0.0

1.2

—

6.15

—

Disorder of the sleep-wake schedule

0.00

-0.00

0.0

1.5

—

5.96

—

Secondary thrombocytopenia

0.00

-0.00

0.0

1.8

—

5.92

—

Unspecified visual impairment (binocular)

0.00

-0.00

0.0

1.6

—

6.44

—

Other encephalitis

0.00

-0.00

0.0

1.6

—

6.17

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

-0.00

0.0

1.7

—

5.56

—

Communicating hydrocephalus

0.00

-0.00

0.0

1.4

—

6.11

—

Other disorders of central nervous system

0.00

-0.00

0.0

1.6

—

6.10

—

Other acute disseminated demyelination

0.00

-0.00

0.0

1.6

—

6.10

—

Corneal degeneration

0.00

-0.00

0.0

1.6

—

6.04

—

Idiopathic thrombocytopenic purpura

0.00

-0.00

0.0

1.3

—

6.18

—

Polyarteritis nodosa and related conditions

0.00

-0.00

0.0

1.6

—

6.04

—

Papilloedema, unspecified

0.00

-0.00

0.0

1.6

—

5.81

—

Small cell lung cancer, helper endpoint

0.00

-0.00

0.0

1.2

—

6.26

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

-0.00

0.0

1.4

—

6.16

—

Burns and corrosions of multiple and unspecified body regions

0.00

-0.00

0.0

1.4

—

5.98

—

Early syphilis, including avohilmo

0.00

-0.00

0.0

1.7

—

5.98

—

0.97

-0.00

1.2

6.50

6.25

mmol/l

—

Amyloidosis, other/unspecified

0.00

-0.00

0.0

1.4

—

6.07

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

0.00

-0.00

0.0

1.2

—

6.10

—

Mental and behavioural disorders associated with the puerperium

0.00

-0.00

0.0

1.4

—

5.79

—

Late syphilis

0.00

-0.00

0.0

1.8

—

5.98

—

Disorder of thyroid, unspecified

0.00

-0.00

0.0

1.6

—

6.02

—

Temporal arteritis

0.00

-0.00

0.0

1.1

—

6.16

—

0.97

-0.00

1.1

6.51

6.29

mmol/l

—

Certain disorders involving the immune mechanism

0.97

-0.00

1.0

1.2

6.30

6.08

mmol/l

—

Other diseases of blood and blood-forming organs, wide

1.01

-0.00

1.0

1.2

6.72

6.03

mmol/l

—

Drug-induced hypoglycaemia without coma

0.00

-0.00

0.0

1.6

—

5.99

—

Other congenital malformations of ear

0.00

-0.00

0.0

1.6

—

5.48

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

-0.00

0.0

1.7

—

5.83

—

Other disorders of thyroid

0.00

-0.00

0.0

1.6

—

6.02

—

Charcot foot

0.00

-0.00

0.0

1.4

—

5.90

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1.02

-0.00

1.8

1.2

6.30

6.07

mmol/l

—

Chromosomal abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.6

—

5.75

—

Other specified and unspecified strabismus

0.00

-0.00

0.0

1.6

—

6.10

—

Cardiomyopathy, Hypertrophic obstructive

0.00

-0.00

0.0

1.2

—

6.10

—

CR(E)ST syndrome

0.00

-0.00

0.0

1.5

—

6.14

—

Beningn neoplasm: Meninges, unspecified

0.00

-0.00

0.0

1.6

—

6.44

—

Hepatocellular carcinoma, including Hilmo

0.00

-0.00

0.0

1.1

—

6.26

—

Melanocytic naevi of eyelid, including canthus

0.00

-0.00

0.0

1.6

—

6.08

—

Malignant neoplasm, without specification of site

0.00

-0.00

0.0

1.1

—

6.08

—

Malignant neoplasm of small intestine

0.00

-0.00

0.0

1.5

—

6.27

—

Small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.2

—

6.15

—

All influenza (not pneumonia)

0.90

-0.00

1.7

1.2

5.87

5.84

mmol/l

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

1.1

—

6.40

—

Disorders of parathyroid gland

0.97

-0.00

1.1

6.14

6.11

mmol/l

—

Malignant neoplasm of oral cavity

0.00

-0.00

0.0

1.5

—

6.33

—

Renal cell carcinoma of kidney

0.00

-0.00

0.0

1.1

—

6.17

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.00

-0.00

0.0

1.7

—

5.97

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.94

-0.00

1.1

5.85

6.16

mmol/l

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

1.6

—

5.96

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

0.00

-0.00

0.0

1.2

—

6.16

—

Venous complications and haemorrhoids in the puerperium

0.00

-0.00

0.0

1.5

—

6.13

—

Colorectal neuroendocrine tumor and carcinoma

0.00

-0.00

0.0

1.5

—

6.26

—

Multiple myeloma

0.00

-0.00

0.0

1.2

—

6.10

—

Carcinoma in situ of breast, other/unspecified

0.00

-0.00

0.0

1.4

—

6.00

—

Malignant neoplasm of oesophagus

0.00

-0.00

0.0

1.2

—

6.56

—

Dermatophytosis

0.88

-0.00

1.0

1.2

5.76

6.07

mmol/l

—

Acute poliomyelitis

0.00

-0.00

0.0

1.6

—

6.40

—

Pediculosis and phthiriasis, including avohilmo

0.00

-0.00

0.0

1.8

—

5.92

—

Fasciculation

0.00

-0.00

0.0

1.5

—

5.98

—

Benign neoplasm of breast

0.88

-0.00

1.4

1.2

5.90

mmol/l

—

Tularaemia, including avohilmo

0.00

-0.00

0.0

1.6

—

6.24

—

Benign neoplasm: Colon, unspecified

0.94

-0.00

1.1

6.20

6.26

mmol/l

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

0.00

-0.00

0.0

1.8

—

5.92

—

Autoimmune hepatitis

0.00

-0.00

0.0

1.2

—

6.74

—

Other congenital malformations, including avohilmo

0.95

-0.00

1.6

1.3

5.84

5.61

mmol/l

—

Other specific arthropathies, wide

0.00

-0.00

0.0

1.4

—

5.96

—

Amputation of foot

0.00

-0.00

0.0

1.6

—

6.24

—

Herpesviral [herpes simplex] infections

0.88

-0.00

1.2

5.82

5.78

mmol/l

—

Candidiasis

0.99

-0.00

1.1

1.3

5.99

5.66

mmol/l

—

Cushing syndrome

0.00

-0.00

0.0

1.6

—

5.88

—

Cardiomyopathy

0.98

-0.00

1.0

1.2

6.36

6.27

mmol/l

—

Acquired haemolytic anaemia

0.00

-0.00

0.0

1.5

—

6.01

—

Hereditary deficiency of other clotting factors

0.00

-0.00

0.0

1.6

—

6.10

—

Need for immunization against other single viral diseases

0.00

-0.00

0.0

1.7

—

5.83

—

Macular pucker

1.02

-0.00

1.0

1.2

6.56

6.27

mmol/l

—

Later onset COPD

0.99

-0.00

1.0

1.1

6.20

6.37

mmol/l

—

Measles

0.00

-0.00

0.0

1.6

—

5.77

—

Superficial injury of forearm

0.85

-0.00

1.2

5.72

5.62

mmol/l

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

-0.00

0.0

1.3

—

5.37

—

Toxic liver disease

0.00

-0.00

0.0

1.7

—

5.97

—

Respiratory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

6.04

—

Mixed connective tissue disease

0.00

-0.00

0.0

1.5

—

5.97

—

Systemic sclerosis (FG)

0.00

-0.00

0.0

1.3

—

5.97

—

Brain glioblastoma and astrocytoma

0.00

-0.00

0.0

1.6

—

6.08

—

Xanthelasma of eyelid

0.00

-0.00

0.0

1.6

—

6.08

—

Palindromic rheumatism

0.00

-0.00

0.0

1.3

—

6.21

—

Other lack of coordination

0.00

-0.00

0.0

1.8

—

5.92

—

Psoas tendinitis

0.00

-0.00

0.0

1.6

—

6.08

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

1.6

—

6.37

—

Foreign body in ear

0.00

-0.00

0.0

1.8

—

5.92

—

Amputation of ankle bones

0.00

-0.00

0.0

1.6

—

5.94

—

Crushing injury of wrist and hand

0.00

-0.00

0.0

1.4

—

5.98

—

Drug-induced cataract

0.00

-0.00

0.0

1.4

—

6.00

—

Foreign body on external eye

0.86

-0.00

1.2

6.44

5.98

mmol/l

—

Budesonide

0.98

-0.00

1.4

1.2

5.75

5.71

mmol/l

—

Burns and corrosions

0.91

-0.00

1.5

1.2

5.72

5.74

mmol/l

—

Systemic sclerosis

0.00

-0.00

0.0

1.4

—

6.06

—

Graves disease, strict definition

0.97

-0.00

1.3

5.30

5.66

mmol/l

—

Hypothermia

0.00

-0.00

0.0

1.8

—

5.92

—

Injury of nerves and spinal cord at neck level

0.00

-0.00

0.0

1.7

—

6.02

—

Injury of nerves at forearm level

0.00

-0.00

0.0

1.4

—

5.98

—

Burn and corrosion of head and neck

0.00

-0.00

0.0

1.7

—

5.83

—

Patent foramen ovale

0.00

-0.00

0.0

1.5

—

6.01

—

Other congenital malformations of circulatory system

0.00

-0.00

0.0

1.5

—

5.91

—

Amyloidosis

0.00

-0.00

0.0

1.3

—

6.04

—

Gender identity disorders

0.00

-0.00

0.0

1.3

—

5.57

—

Giant cell arteritis

0.00

-0.00

0.0

1.3

—

6.04

—

Deficiency of other B group vitamins

0.00

-0.00

0.0

1.5

—

6.10

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS